firstpost_date,url,trackback_author_nick,content,score,trackback_permalink,trackback_author_url
01/03/14,http://twitter.com/maurerstats/status/419242134026211328,maurerstats,"FLC, cytokines, and outcome in dlbcl. Preprint on web at AJH http://t.co/ggoExqMUKN #lymphoma #lymsm",8.129802,http://twitter.com/MaurerStats/status/419242134026211328,http://twitter.com/maurerstats
01/04/14,http://twitter.com/tbssteharding/status/419372029599813632,tbssteharding,"RT @MaurerStats: FLC, cytokines, and outcome in dlbcl. Preprint on web at AJH http://t.co/ggoExqMUKN #lymphoma #lymsm",7.1065793,http://twitter.com/TBSsteharding/status/419372029599813632,http://twitter.com/tbssteharding
01/07/14,http://twitter.com/drmiguelperales/status/420628898293223424,drmiguelperales,"RT @Reuters_Health J&amp;J, Pharmacyclics leukemia drug succeeds in late-stage study http://t.co/WqaF94W0JW #lymsm #CLL",7.1186647,http://twitter.com/DrMiguelPerales/status/420628898293223424,http://twitter.com/drmiguelperales
01/08/14,http://twitter.com/drmiguelperales/status/420931435462004738,drmiguelperales,Important study MT @ASCOPost Better OS w AlloHCT vs Conventional Chemo in Postremission Rx for AML http://t.co/kplZalMxvz  #lymsm #bmtsm,7.150361,http://twitter.com/DrMiguelPerales/status/420931435462004738,http://twitter.com/drmiguelperales
01/08/14,http://twitter.com/eaonc/status/420939979087675392,eaonc,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/UMmJCa7l6C #EAOnc,11.47659,http://twitter.com/eaonc/status/420939979087675392,http://twitter.com/eaonc
01/08/14,http://twitter.com/mtmdphd/status/420939978206879744,mtmdphd,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/nk8MigOyhV #EAOnc,10.1791525,http://twitter.com/mtmdphd/status/420939978206879744,http://twitter.com/mtmdphd
01/09/14,http://twitter.com/mtmdphd/status/421296802684751872,mtmdphd,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/et6NDDx22w #EAOnc,10.899422,http://twitter.com/mtmdphd/status/421296802684751872,http://twitter.com/mtmdphd
01/09/14,http://twitter.com/eaonc/status/421296804156952576,eaonc,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/ZKROVWDnF3 #EAOnc,6.894181,http://twitter.com/eaonc/status/421296804156952576,http://twitter.com/eaonc
01/09/14,http://twitter.com/smerv/status/421298215372091392,smerv,RT @mtmdphd: ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/et6NDDx22w #EAOnc,9.960063,http://twitter.com/smerv/status/421298215372091392,http://twitter.com/smerv
01/09/14,http://twitter.com/lymphomahub/status/421379727455444992,lymphomahub,"RT @mtmdphd ""ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm   #EAOnc"" http://t.co/ro2VY6mn7S",6.796786,http://twitter.com/lymphomahub/status/421379727455444992,http://twitter.com/lymphomahub
01/10/14,http://twitter.com/mtmdphd/status/421701948270587904,mtmdphd,RT @eaonc: ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/UMmJCa7l6C #EAOnc,9.935806,http://twitter.com/mtmdphd/status/421701948270587904,http://twitter.com/mtmdphd
01/10/14,http://twitter.com/maurerstats/status/421711357050761216,maurerstats,RT @eaonc: ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/UMmJCa7l6C #EAOnc,6.7488847,http://twitter.com/MaurerStats/status/421711357050761216,http://twitter.com/maurerstats
01/10/14,http://twitter.com/maurerstats/status/421721590145900544,maurerstats,Just enrolled the 6000th patient on our #lymphoma molecular epidemiology resource study.  #lymsm,7.6748447,http://twitter.com/MaurerStats/status/421721590145900544,http://twitter.com/maurerstats
01/10/14,http://twitter.com/mtmdphd/status/421751781384007680,mtmdphd,Low BMD &amp; High Bone Turnover In NHL Pts on Frontline Therapy - Anargyrou et al. #ASH10 http://t.co/Un0RVgyCce #lymsm,10.140658,http://twitter.com/mtmdphd/status/421751781384007680,http://twitter.com/mtmdphd
01/10/14,http://twitter.com/mtmdphd/status/421761821843128320,mtmdphd,Elderly NHL Pts on chemotherapy are at higher risk for osteoporosis &amp; fractures - Cabanillas et al. 2007 http://t.co/VPhUERz01G #lymsm,10.412678,http://twitter.com/mtmdphd/status/421761821843128320,http://twitter.com/mtmdphd
01/11/14,http://twitter.com/mdandersonnews/status/421998415434612737,mdandersonnews,Mantle cell #lymphoma research receives $1 million boost: http://t.co/zDVhP5dR3H #endancer #lymsm,12.838642,http://twitter.com/MDAndersonNews/status/421998415434612737,http://twitter.com/mdandersonnews
01/11/14,http://twitter.com/emircervera/status/422009088080224257,emircervera,RT @MDAndersonNews: Mantle cell #lymphoma research receives $1 million boost: http://t.co/zDVhP5dR3H #endancer #lymsm,7.4218407,http://twitter.com/emircervera/status/422009088080224257,http://twitter.com/emircervera
01/11/14,http://twitter.com/dawnka/status/422011087630782464,dawnka,Great news!!!--&gt; @MDAndersonNews Mantle cell #lymphoma research receives $1million boost http://t.co/OhWw5jdQI0  #endancer #lymsm #celebrate,10.580483,http://twitter.com/DawnKA/status/422011087630782464,http://twitter.com/dawnka
01/11/14,http://twitter.com/jdarsee/status/422061046971760640,jdarsee,RT @MDAndersonNews: Mantle cell #lymphoma research receives $1 million boost: http://t.co/zDVhP5dR3H #endancer #lymsm,7.4218407,http://twitter.com/jdarsee/status/422061046971760640,http://twitter.com/jdarsee
01/11/14,http://twitter.com/twittmanda/status/422061084485234689,twittmanda,RT @MDAndersonNews: Mantle cell #lymphoma research receives $1 million boost: http://t.co/zDVhP5dR3H #endancer #lymsm,7.4218407,http://twitter.com/twittmanda/status/422061084485234689,http://twitter.com/twittmanda
01/11/14,http://twitter.com/muslime1mystery/status/422085775321489409,muslime1mystery,RT @eaonc: ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/UMmJCa7l6C #EAOnc,6.7488847,http://twitter.com/muslime1mystery/status/422085775321489409,http://twitter.com/muslime1mystery
01/11/14,http://twitter.com/paczie/status/422087629661011968,paczie,RT @MDAndersonNews: Mantle cell #lymphoma research receives $1 million boost: http://t.co/zDVhP5dR3H #endancer #lymsm,10.618725,http://twitter.com/Paczie/status/422087629661011968,http://twitter.com/paczie
01/11/14,http://twitter.com/timallenmdjd/status/422142179075571712,timallenmdjd,RT @MDAndersonNews: Mantle cell #lymphoma research receives $1 million boost: http://t.co/zDVhP5dR3H #endancer #lymsm,10.607501,http://twitter.com/TimAllenMDJD/status/422142179075571712,http://twitter.com/timallenmdjd
01/16/14,http://twitter.com/drmiguelperales/status/423664020659269632,drmiguelperales,"Nice review by @timfenske AlloHCTfor diffuse large B cell lymphoma: who, when and how? http://t.co/gntlIOImLA #bmtsm #lymsm",8.050963,http://twitter.com/DrMiguelPerales/status/423664020659269632,http://twitter.com/drmiguelperales
01/16/14,http://twitter.com/mtmdphd/status/423802089136222208,mtmdphd,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/JK8qfuFlSF #EAOnc,10.111642,http://twitter.com/mtmdphd/status/423802089136222208,http://twitter.com/mtmdphd
01/16/14,http://twitter.com/eaonc/status/423802090096705536,eaonc,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/W8XQgynkAh #EAOnc,6.8843775,http://twitter.com/eaonc/status/423802090096705536,http://twitter.com/eaonc
01/16/14,http://twitter.com/lymphomahub/status/423920249504038912,lymphomahub,"RT @mtmdphd ""ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm   #EAOnc"" http://t.co/q6lRLtVteu",6.815907,http://twitter.com/lymphomahub/status/423920249504038912,http://twitter.com/lymphomahub
01/19/14,http://twitter.com/drmiguelperales/status/425029764726784000,drmiguelperales,Open trial @sloan_kettering AutoSCT + CD19-CAR TCells for Rel/Ref B-NHL #lymphoma http://t.co/JQu7IxM2OE   #bmtsm #lymsm,9.189172,http://twitter.com/DrMiguelPerales/status/425029764726784000,http://twitter.com/drmiguelperales
01/19/14,http://twitter.com/drmiguelperales/status/425035090389790720,drmiguelperales,Open trial @sloan_kettering Allo-SCT for patient with advanced #Hodgkin lymphoma http://t.co/RTqwXU9Km2 #lymsm #bmtsm,8.767029,http://twitter.com/DrMiguelPerales/status/425035090389790720,http://twitter.com/drmiguelperales
01/19/14,http://twitter.com/drmiguelperales/status/425035170387742720,drmiguelperales,Open trial @sloan_kettering Ph 2 Study AutoSCT w maintenance Romidepsin in T cell NHL. #lymphoma http://t.co/FtQdDW0c0l #lymsm #bmtsm,7.9708014,http://twitter.com/DrMiguelPerales/status/425035170387742720,http://twitter.com/drmiguelperales
01/19/14,http://twitter.com/dranasyounes/status/425035392258420736,dranasyounes,RT @DrMiguelPerales: Open trial @sloan_kettering Allo-SCT for patient with advanced #Hodgkin lymphoma http://t.co/Jw2im8fAmV #lymsm #bmtsm,10.337261,http://twitter.com/DrAnasYounes/status/425035392258420736,http://twitter.com/dranasyounes
01/19/14,http://twitter.com/drmiguelperales/status/425035735192715264,drmiguelperales,Stem Cell Transplant Clinical trials @sloan_kettering http://t.co/3rWkC6bjm5 #bmtsm #mmsm #leusm #lymsm,8.0605,http://twitter.com/DrMiguelPerales/status/425035735192715264,http://twitter.com/drmiguelperales
01/19/14,http://twitter.com/maverickny/status/425036195585097729,maverickny,RT @DrMiguelPerales Open trial @sloan_kettering AutoSCT + CD19-CAR TCells for Rel/Ref B-NHL #lymphoma http://t.co/Ce3kV980KG   #bmtsm #lymsm,10.173082,http://twitter.com/MaverickNY/status/425036195585097729,http://twitter.com/maverickny
01/19/14,http://twitter.com/mskhemonctrials/status/425045557057298432,mskhemonctrials,RT @DrMiguelPerales: Stem Cell Transplant Clinical trials @sloan_kettering http://t.co/3rWkC6bjm5 #bmtsm #mmsm #leusm #lymsm,7.026391,http://twitter.com/MSKHemOncTrials/status/425045557057298432,http://twitter.com/mskhemonctrials
01/19/14,http://twitter.com/mskhemonctrials/status/425051485760913408,mskhemonctrials,RT @DrMiguelPerales: Open trial @sloan_kettering Ph 2 Study AutoSCT w maintenance Romidepsin in T cell NHL. #lymphoma http://t.co/FtQdDW0c0…,7.042348,http://twitter.com/MSKHemOncTrials/status/425051485760913408,http://twitter.com/mskhemonctrials
01/19/14,http://twitter.com/mskhemonctrials/status/425051494174715905,mskhemonctrials,RT @DrMiguelPerales: Open trial @sloan_kettering Allo-SCT for patient with advanced #Hodgkin lymphoma http://t.co/RTqwXU9Km2 #lymsm #bmtsm,6.9849534,http://twitter.com/MSKHemOncTrials/status/425051494174715905,http://twitter.com/mskhemonctrials
01/19/14,http://twitter.com/mskhemonctrials/status/425051528731582464,mskhemonctrials,RT @DrMiguelPerales: Open trial @sloan_kettering AutoSCT + CD19-CAR TCells for Rel/Ref B-NHL #lymphoma http://t.co/JQu7IxM2OE   #bmtsm #lym…,6.6255007,http://twitter.com/MSKHemOncTrials/status/425051528731582464,http://twitter.com/mskhemonctrials
01/20/14,http://twitter.com/j_jay_z/status/425088806124257281,j_jay_z,RT @DrMiguelPerales: Open trial @sloan_kettering AutoSCT + CD19-CAR TCells for Rel/Ref B-NHL #lymphoma http://t.co/JQu7IxM2OE   #bmtsm #lym…,6.6255007,http://twitter.com/j_jay_z/status/425088806124257281,http://twitter.com/j_jay_z
01/20/14,http://twitter.com/asco/status/425327953413935104,asco,#JCO: Follow-Up of Patients With Breast Implant–Associated ALCL #lymsm http://t.co/mHslgVbAwk,11.9524355,http://twitter.com/ASCO/status/425327953413935104,http://twitter.com/asco
01/20/14,http://twitter.com/ibcresearch/status/425332728859353089,ibcresearch,"""@ASCO: #JCO: Follow-Up of Patients With Breast Implant–Associated ALCL #lymsm http://t.co/nmM6ILFWff"".  Important read. #IBC",7.8505335,http://twitter.com/IBCResearch/status/425332728859353089,http://twitter.com/ibcresearch
01/20/14,http://twitter.com/grwakefield49/status/425333879927754752,grwakefield49,RT @ASCO: #JCO: Follow-Up of Patients With Breast Implant–Associated ALCL #lymsm http://t.co/mHslgVbAwk,7.07759,http://twitter.com/grwakefield49/status/425333879927754752,http://twitter.com/grwakefield49
01/20/14,http://twitter.com/mknoll_md/status/425357055449649152,mknoll_md,RT @ASCO: #JCO: Follow-Up of Patients With Breast Implant–Associated ALCL #lymsm http://t.co/mHslgVbAwk,7.07759,http://twitter.com/MKnoll_MD/status/425357055449649152,http://twitter.com/mknoll_md
01/20/14,http://twitter.com/cancergeek/status/425371927168172032,cancergeek,"Cancer: Robin Roberts Appears Public Service Campaign http://t.co/3k3tcfwqh1
#cancer #hcmktg #leusm #lymsm #bcsm",7.48779,http://twitter.com/CancerGeek/status/425371927168172032,http://twitter.com/cancergeek
01/20/14,http://twitter.com/abeknoll/status/425376081341075456,abeknoll,RT @ASCO: #JCO: Follow-Up of Patients With Breast Implant–Associated ALCL #lymsm http://t.co/mHslgVbAwk,7.07759,http://twitter.com/AbeKnoll/status/425376081341075456,http://twitter.com/abeknoll
01/22/14,http://twitter.com/mdandersonnews/status/425808820389281792,mdandersonnews,10 symptoms of non-hodgkin’s lymphoma: http://t.co/xVMJMr9Ugx #lymsm #endcancer,12.841583,http://twitter.com/MDAndersonNews/status/425808820389281792,http://twitter.com/mdandersonnews
01/22/14,http://twitter.com/drduanehassane/status/425811877617475585,drduanehassane,RT @MDAndersonNews: 10 symptoms of non-hodgkin’s lymphoma: http://t.co/xVMJMr9Ugx #lymsm #endcancer,7.3037524,http://twitter.com/DrDuaneHassane/status/425811877617475585,http://twitter.com/drduanehassane
01/22/14,http://twitter.com/dawnka/status/425814274645438464,dawnka,RT @MDAndersonNews: 10 symptoms of non-hodgkin’s lymphoma: http://t.co/xVMJMr9Ugx #lymsm #endcancer,10.524296,http://twitter.com/DawnKA/status/425814274645438464,http://twitter.com/dawnka
01/22/14,http://twitter.com/ckesserwan/status/425836230664671232,ckesserwan,RT @DrMiguelPerales: Open trial @sloan_kettering AutoSCT + CD19-CAR TCells for Rel/Ref B-NHL #lymphoma http://t.co/JQu7IxM2OE   #bmtsm #lym…,6.6255007,http://twitter.com/ckesserwan/status/425836230664671232,http://twitter.com/ckesserwan
01/22/14,http://twitter.com/onacom/status/426002972011921409,onacom,RT @MDAndersonNews: 10 symptoms of non-hodgkin’s lymphoma: http://t.co/eWmfiHXpxv #lymsm #endcancer,8.170145,http://twitter.com/ONAcom/status/426002972011921409,http://twitter.com/onacom
01/22/14,http://twitter.com/healthorder/status/426004646562635777,healthorder,RT @ONAcom: RT @MDAndersonNews: 10 symptoms of non-hodgkin’s lymphoma: http://t.co/eWmfiHXpxv #lymsm #endcancer,7.146922,http://twitter.com/healthorder/status/426004646562635777,http://twitter.com/healthorder
01/22/14,http://twitter.com/asco/status/426060633046798336,asco,Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,13.083883,http://twitter.com/ASCO/status/426060633046798336,http://twitter.com/asco
01/22/14,http://twitter.com/healthorder/status/426062820372131840,healthorder,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,7.186483,http://twitter.com/healthorder/status/426062820372131840,http://twitter.com/healthorder
01/22/14,http://twitter.com/j_jay_z/status/426063343791898625,j_jay_z,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,7.186483,http://twitter.com/j_jay_z/status/426063343791898625,http://twitter.com/j_jay_z
01/22/14,http://twitter.com/crwlibrary/status/426063564986912768,crwlibrary,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,7.186483,http://twitter.com/CRWLibrary/status/426063564986912768,http://twitter.com/crwlibrary
01/22/14,http://twitter.com/thenci/status/426066232220340224,thenci,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,10.471112,http://twitter.com/theNCI/status/426066232220340224,http://twitter.com/thenci
01/22/14,http://twitter.com/elizabethstime/status/426067280410472449,elizabethstime,“@ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/MsqiplyQUP #JOP #lymsm #lylhd”@CNIO_Cancer @IRBBarcelona @CR_UK,6.9233365,http://twitter.com/Elizabethstime/status/426067280410472449,http://twitter.com/elizabethstime
01/22/14,http://twitter.com/anthony_cadogan/status/426068125705334784,anthony_cadogan,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,7.186483,http://twitter.com/anthony_cadogan/status/426068125705334784,http://twitter.com/anthony_cadogan
01/22/14,http://twitter.com/pharma_mty/status/426083218887307265,pharma_mty,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,7.186483,http://twitter.com/Pharma_Mty/status/426083218887307265,http://twitter.com/pharma_mty
01/22/14,http://twitter.com/scopedbylarry/status/426083672396398593,scopedbylarry,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,10.477298,http://twitter.com/scopedbylarry/status/426083672396398593,http://twitter.com/scopedbylarry
01/22/14,http://twitter.com/alexluv27/status/426098890170191873,alexluv27,RT @MDAndersonNews: 10 symptoms of non-hodgkin’s lymphoma: http://t.co/xVMJMr9Ugx #lymsm #endcancer,7.3037524,http://twitter.com/alexluv27/status/426098890170191873,http://twitter.com/alexluv27
01/22/14,http://twitter.com/marilyn214/status/426129212203089920,marilyn214,RT @MDAndersonNews: 10 symptoms of non-hodgkin’s lymphoma: http://t.co/xVMJMr9Ugx #lymsm #endcancer,7.3037524,http://twitter.com/Marilyn214/status/426129212203089920,http://twitter.com/marilyn214
01/23/14,http://twitter.com/afican_princess/status/426175405977251841,afican_princess,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/12hfo1YPiD #JOP #lymsm #lylhd,7.186483,http://twitter.com/afican_Princess/status/426175405977251841,http://twitter.com/afican_princess
01/23/14,http://twitter.com/fischmd/status/426182832504197120,fischmd,Terrific waterfall plot: MT @NEJM: Idelalisib is active for heavily pretreated pts w/indolent #lymphoma http://t.co/2Y0uFFPUKx #lymsm,11.391654,http://twitter.com/fischmd/status/426182832504197120,http://twitter.com/fischmd
01/23/14,http://twitter.com/healthorder/status/426183472647249920,healthorder,RT @fischmd: Terrific waterfall plot: MT @NEJM: Idelalisib is active for heavily pretreated pts w/indolent #lymphoma http://t.co/2Y0uFFPUKx…,6.970613,http://twitter.com/healthorder/status/426183472647249920,http://twitter.com/healthorder
01/23/14,http://twitter.com/harshadod/status/426188314308509696,harshadod,RT @fischmd: Terrific waterfall plot: MT @NEJM: Idelalisib is active for heavily pretreated pts w/indolent #lymphoma http://t.co/2Y0uFFPUKx…,6.970613,http://twitter.com/Harshadod/status/426188314308509696,http://twitter.com/harshadod
01/23/14,http://twitter.com/chuebner15/status/426196961839316992,chuebner15,RT @MDAndersonNews: 10 symptoms of non-hodgkin’s lymphoma: http://t.co/xVMJMr9Ugx #lymsm #endcancer,7.3037524,http://twitter.com/chuebner15/status/426196961839316992,http://twitter.com/chuebner15
01/23/14,http://twitter.com/cardiooncology/status/426218576778100736,cardiooncology,“@ASCO: Excellent perspective on Rx of Hodgkin Lymphoma by Canellos and colleagues http://t.co/VgR8biQXcN #JOP #lymsm #lylhd”,8.110267,http://twitter.com/CardioOncology/status/426218576778100736,http://twitter.com/cardiooncology
01/23/14,http://twitter.com/healthorder/status/426257172553809920,healthorder,RT @CardioOncology: “@ASCO: Excellent perspective on Rx of Hodgkin Lymphoma by Canellos and colleagues http://t.co/VgR8biQXcN #JOP #lymsm #…,7.063587,http://twitter.com/healthorder/status/426257172553809920,http://twitter.com/healthorder
01/24/14,http://twitter.com/heathercunliffe/status/426733182918991872,heathercunliffe,"RT @IBCResearch: ""@ASCO: #JCO: Follow-Up of Patients With Breast Implant–Associated ALCL #lymsm http://t.co/nmM6ILFWff"".  Important read. #…",6.9099016,http://twitter.com/HeatherCunliffe/status/426733182918991872,http://twitter.com/heathercunliffe
01/24/14,http://twitter.com/drmiguelperales/status/426786639419936768,drmiguelperales,Subcut rituximab: Roche says EU panel backs lymphatic cancer drug for approval http://t.co/n9oHV7dk1s via @reuters #lymsm,8.043882,http://twitter.com/DrMiguelPerales/status/426786639419936768,http://twitter.com/drmiguelperales
01/24/14,http://twitter.com/healthorder/status/426793152511770625,healthorder,RT @DrMiguelPerales: Subcut rituximab: Roche says EU panel backs lymphatic cancer drug for approval http://t.co/n9oHV7dk1s via @reuters #ly…,7.0859804,http://twitter.com/healthorder/status/426793152511770625,http://twitter.com/healthorder
01/24/14,http://twitter.com/cancerdotnet/status/426801665594097664,cancerdotnet,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/QewqPDI6iR #JOP #lymsm #lylhd,8.840919,http://twitter.com/CancerDotNet/status/426801665594097664,http://twitter.com/cancerdotnet
01/24/14,http://twitter.com/healthorder/status/426808473725448194,healthorder,RT @CancerDotNet: RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/QewqPDI6iR #JOP #lymsm #lylhd,7.095926,http://twitter.com/healthorder/status/426808473725448194,http://twitter.com/healthorder
01/25/14,http://twitter.com/mariamaharraz/status/427146184114069504,mariamaharraz,RT @MDAndersonNews: 10 symptoms of non-hodgkin’s lymphoma: http://t.co/xVMJMr9Ugx #lymsm #endcancer,7.5951204,http://twitter.com/Mariamaharraz/status/427146184114069504,http://twitter.com/mariamaharraz
01/25/14,http://twitter.com/drmiguelperales/status/427201750496342017,drmiguelperales,For info about clinical trials in hematologic malignancies @sloan_kettering follow @MSKHemOncTrials #leusm #lymsm #mmsm #bmtsm,12.193714,http://twitter.com/DrMiguelPerales/status/427201750496342017,http://twitter.com/drmiguelperales
01/25/14,http://twitter.com/sloan_kettering/status/427202658525786112,sloan_kettering,RT @DrMiguelPerales: For info about clinical trials in hematologic malignancies @sloan_kettering follow @MSKHemOncTrials #leusm #lymsm #mms…,10.066198,http://twitter.com/sloan_kettering/status/427202658525786112,http://twitter.com/sloan_kettering
01/25/14,http://twitter.com/vshealer/status/427203108423614464,vshealer,RT @DrMiguelPerales: For info about clinical trials in hematologic malignancies @sloan_kettering follow @MSKHemOncTrials #leusm #lymsm #mms…,6.8108187,http://twitter.com/VShealer/status/427203108423614464,http://twitter.com/vshealer
01/25/14,http://twitter.com/aspo1962/status/427203201289293824,aspo1962,RT @DrMiguelPerales: For info about clinical trials in hematologic malignancies @sloan_kettering follow @MSKHemOncTrials #leusm #lymsm #mms…,6.8108187,http://twitter.com/Aspo1962/status/427203201289293824,http://twitter.com/aspo1962
01/25/14,http://twitter.com/beardslc/status/427204105275449345,beardslc,RT @DrMiguelPerales: For info about clinical trials in hematologic malignancies @sloan_kettering follow @MSKHemOncTrials #leusm #lymsm #mms…,6.8108187,http://twitter.com/beardslc/status/427204105275449345,http://twitter.com/beardslc
01/25/14,http://twitter.com/naborala/status/427204632793075712,naborala,RT @DrMiguelPerales: For info about clinical trials in hematologic malignancies @sloan_kettering follow @MSKHemOncTrials #leusm #lymsm #mms…,6.8108187,http://twitter.com/naborala/status/427204632793075712,http://twitter.com/naborala
01/25/14,http://twitter.com/mskcc_library/status/427205552025137152,mskcc_library,RT @DrMiguelPerales: For info about clinical trials in hematologic malignancies @sloan_kettering follow @MSKHemOncTrials #leusm #lymsm #mms…,6.8108187,http://twitter.com/MSKCC_Library/status/427205552025137152,http://twitter.com/mskcc_library
01/27/14,http://twitter.com/asco/status/427617058969624576,asco,Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/3cmQizGBRb #lymsm #lylhd,12.720489,http://twitter.com/ASCO/status/427617058969624576,http://twitter.com/asco
01/27/14,http://twitter.com/kettyveraa/status/427617171687358464,kettyveraa,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/3cmQizGBRb #lymsm #lylhd,7.249153,http://twitter.com/KettyVeraA/status/427617171687358464,http://twitter.com/kettyveraa
01/27/14,http://twitter.com/onced/status/427622751826743296,onced,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/3cmQizGBRb #lymsm #lylhd,7.249153,http://twitter.com/OncEd/status/427622751826743296,http://twitter.com/onced
01/27/14,http://twitter.com/healthorder/status/427640525479739392,healthorder,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/3cmQizGBRb #lymsm #lylhd,7.249153,http://twitter.com/healthorder/status/427640525479739392,http://twitter.com/healthorder
01/27/14,http://twitter.com/biomoticeo/status/427672011838873600,biomoticeo,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/3cmQizGBRb #lymsm #lylhd,7.249153,http://twitter.com/biomotiCEO/status/427672011838873600,http://twitter.com/biomoticeo
01/27/14,http://twitter.com/tony_biotech/status/427690448329916416,tony_biotech,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/3cmQizGBRb #lymsm #lylhd,7.249153,http://twitter.com/tony_biotech/status/427690448329916416,http://twitter.com/tony_biotech
01/27/14,http://twitter.com/j_jay_z/status/427703620445171712,j_jay_z,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/3cmQizGBRb #lymsm #lylhd,7.249153,http://twitter.com/j_jay_z/status/427703620445171712,http://twitter.com/j_jay_z
01/28/14,http://twitter.com/asco/status/428167022829395968,asco,Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/Lf945wHHk9 #lymsm #lylhd,12.532916,http://twitter.com/ASCO/status/428167022829395968,http://twitter.com/asco
01/28/14,http://twitter.com/thedura01/status/428168286241820672,thedura01,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/Lf945wHHk9 #lymsm #lylhd,7.419041,http://twitter.com/TheDura01/status/428168286241820672,http://twitter.com/thedura01
01/28/14,http://twitter.com/isgsolutions/status/428171373480259584,isgsolutions,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/Lf945wHHk9 #lymsm #lylhd,7.419041,http://twitter.com/ISGsolutions/status/428171373480259584,http://twitter.com/isgsolutions
01/28/14,http://twitter.com/rickbeardmore/status/428174936591831040,rickbeardmore,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/Lf945wHHk9 #lymsm #lylhd,7.419041,http://twitter.com/RickBeardmore/status/428174936591831040,http://twitter.com/rickbeardmore
01/28/14,http://twitter.com/meganpharmd/status/428193292090482688,meganpharmd,@DavidDeRemer Check out @ASCO Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/CQuOKNBoE4  #lymsm #lylhd,7.284172,http://twitter.com/MeganPharmD/status/428193292090482688,http://twitter.com/meganpharmd
01/28/14,http://twitter.com/mdandersonnews/status/428227784381849600,mdandersonnews,No one thought Marvin Kimmel would walk again after #cancer — except Marvin Kimmel. http://t.co/N6ZnBvWeFG #lymsm #endcancer,11.948689,http://twitter.com/MDAndersonNews/status/428227784381849600,http://twitter.com/mdandersonnews
01/28/14,http://twitter.com/healthorder/status/428232869648281601,healthorder,RT @MDAndersonNews: No one thought Marvin Kimmel would walk again after #cancer — except Marvin Kimmel. http://t.co/N6ZnBvWeFG #lymsm #endc…,7.3548822,http://twitter.com/healthorder/status/428232869648281601,http://twitter.com/healthorder
01/28/14,http://twitter.com/eileengrubba/status/428280799675162625,eileengrubba,RT @MDAndersonNews: No one thought Marvin Kimmel would walk again after #cancer — except Marvin Kimmel. http://t.co/N6ZnBvWeFG #lymsm #endc…,10.566989,http://twitter.com/EileenGrubba/status/428280799675162625,http://twitter.com/eileengrubba
01/28/14,http://twitter.com/gotheimer/status/428298587249057792,gotheimer,RT @ASCO: Treatment of Hodgkin Lymphoma: A 50-Year Perspective http://t.co/Lf945wHHk9 #lymsm #lylhd,7.419041,http://twitter.com/gotheimer/status/428298587249057792,http://twitter.com/gotheimer
02/03/14,http://twitter.com/asco/status/430454553222594560,asco,Transplantation in Mantle-Cell Lymphoma: Analysis of Transplanation Timing &amp; Modality #JCO  http://t.co/rtdFErhnCL #lymsm,11.825032,http://twitter.com/ASCO/status/430454553222594560,http://twitter.com/asco
02/03/14,http://twitter.com/ericglazer/status/430455351511875584,ericglazer,RT @ASCO: Transplantation in Mantle-Cell Lymphoma: Analysis of Transplanation Timing &amp; Modality #JCO  http://t.co/SWfDmGzJE1 #lymsm,6.8290343,http://twitter.com/EricGlazer/status/430455351511875584,http://twitter.com/ericglazer
02/03/14,http://twitter.com/emircervera/status/430456394408398848,emircervera,RT @ASCO: Transplantation in Mantle-Cell Lymphoma: Analysis of Transplanation Timing &amp; Modality #JCO  http://t.co/rtdFErhnCL #lymsm,6.9536138,http://twitter.com/emircervera/status/430456394408398848,http://twitter.com/emircervera
02/04/14,http://twitter.com/asco/status/430732878440579072,asco,R-GCVP for Patients With DLBCL Unsuitable for R-CHOP  http://t.co/sawoBaEb12 #JCO  #lymsm,12.427632,http://twitter.com/ASCO/status/430732878440579072,http://twitter.com/asco
02/04/14,http://twitter.com/looking4unknown/status/430734749024661504,looking4unknown,RT @ASCO: R-GCVP for Patients With DLBCL Unsuitable for R-CHOP  http://t.co/sawoBaEb12 #JCO  #lymsm,6.8991385,http://twitter.com/looking4unknown/status/430734749024661504,http://twitter.com/looking4unknown
02/04/14,http://twitter.com/healthorder/status/430737080675991553,healthorder,RT @ASCO: R-GCVP for Patients With DLBCL Unsuitable for R-CHOP  http://t.co/sawoBaEb12 #JCO  #lymsm,6.8991385,http://twitter.com/healthorder/status/430737080675991553,http://twitter.com/healthorder
02/04/14,http://twitter.com/szusmani/status/430750386316537856,szusmani,RT @ASCO: R-GCVP for Patients With DLBCL Unsuitable for R-CHOP  http://t.co/sawoBaEb12 #JCO  #lymsm,6.8991385,http://twitter.com/szusmani/status/430750386316537856,http://twitter.com/szusmani
02/04/14,http://twitter.com/mtmdphd/status/430796316386816000,mtmdphd,RT @ASCO: R-GCVP for Patients With DLBCL Unsuitable for R-CHOP  http://t.co/sawoBaEb12 #JCO  #lymsm,10.08606,http://twitter.com/mtmdphd/status/430796316386816000,http://twitter.com/mtmdphd
02/04/14,http://twitter.com/babysdoc/status/430796742561656832,babysdoc,RT @ASCO: R-GCVP for Patients With DLBCL Unsuitable for R-CHOP  http://t.co/sawoBaEb12 #JCO  #lymsm,6.8991385,http://twitter.com/babysdoc/status/430796742561656832,http://twitter.com/babysdoc
02/04/14,http://twitter.com/ichiyam/status/430819958042288130,ichiyam,RT @ASCO: R-GCVP for Patients With DLBCL Unsuitable for R-CHOP  http://t.co/sawoBaEb12 #JCO  #lymsm,6.8991385,http://twitter.com/ichiyam/status/430819958042288130,http://twitter.com/ichiyam
02/07/14,http://twitter.com/drmiguelperales/status/431811847537184768,drmiguelperales,Stem Cell Transplant Clinical trials @sloan_kettering http://t.co/3rWkC6bjm5 http://t.co/ja6arEiyAh #bmtsm #mmsm #leusm #lymsm,9.202937,http://twitter.com/DrMiguelPerales/status/431811847537184768,http://twitter.com/drmiguelperales
02/07/14,http://twitter.com/mskcc_library/status/431819966292451328,mskcc_library,RT @DrMiguelPerales: Stem Cell Transplant Clinical trials @sloan_kettering http://t.co/3rWkC6bjm5 http://t.co/ja6arEiyAh #bmtsm #mmsm #leus…,7.0034094,http://twitter.com/MSKCC_Library/status/431819966292451328,http://twitter.com/mskcc_library
02/07/14,http://twitter.com/mskhemonctrials/status/431827707702562816,mskhemonctrials,RT @DrMiguelPerales: Stem Cell Transplant Clinical trials @sloan_kettering http://t.co/3rWkC6bjm5 http://t.co/ja6arEiyAh #bmtsm #mmsm #leus…,7.0034094,http://twitter.com/MSKHemOncTrials/status/431827707702562816,http://twitter.com/mskhemonctrials
02/12/14,http://twitter.com/mtmdphd/status/433718284694089728,mtmdphd,Zoledronic acid for prevention of bone loss in lymphomas - Ph 3 RCT - @Lymphoma_Doc @mtmdphd et al. CLML http://t.co/usxpEKJ9jm #lymsm,11.461619,http://twitter.com/mtmdphd/status/433718284694089728,http://twitter.com/mtmdphd
02/12/14,http://twitter.com/mortgages4mds/status/433718387710373888,mortgages4mds,RT @mtmdphd: Zoledronic acid for prevention of bone loss in lymphomas - Ph 3 RCT - @Lymphoma_Doc @mtmdphd et al. CLML http://t.co/usxpEKJ9j…,6.725536,http://twitter.com/Mortgages4MDs/status/433718387710373888,http://twitter.com/mortgages4mds
02/12/14,http://twitter.com/drzafergokgoz/status/433720039343423488,drzafergokgoz,RT @mtmdphd: Zoledronic acid for prevention of bone loss in lymphomas - Ph 3 RCT - @Lymphoma_Doc @mtmdphd et al. CLML http://t.co/usxpEKJ9j…,6.725536,http://twitter.com/drzafergokgoz/status/433720039343423488,http://twitter.com/drzafergokgoz
02/12/14,http://twitter.com/lymphomamyeloma/status/433743216970444801,lymphomamyeloma,RT @mtmdphd: Zoledronic acid for prevention of bone loss in lymphomas - Ph 3 RCT - @Lymphoma_Doc @mtmdphd et al. CLML http://t.co/usxpEKJ9j…,6.725536,http://twitter.com/LymphomaMyeloma/status/433743216970444801,http://twitter.com/lymphomamyeloma
02/13/14,http://twitter.com/danafarber/status/434089607068934144,danafarber,"In a recent webcast, Dr. Ann Lacasce talks about potential for newly approved #ibrutinib (@ 12:50 mark) http://t.co/kngZQcY1bl #leusm #lymsm",12.138508,http://twitter.com/DanaFarber/status/434089607068934144,http://twitter.com/danafarber
02/13/14,http://twitter.com/gazulides/status/434094290130567169,gazulides,"RT @DanaFarber: In a recent webcast, Dr. Ann Lacasce talks about potential for newly approved #ibrutinib (@ 12:50 mark) http://t.co/kngZQcY…",7.180185,http://twitter.com/Gazulides/status/434094290130567169,http://twitter.com/gazulides
02/13/14,http://twitter.com/markwatson74/status/434095900848570368,markwatson74,"RT @DanaFarber: In a recent webcast, Dr. Ann Lacasce talks about potential for newly approved #ibrutinib (@ 12:50 mark) http://t.co/kngZQcY…",7.180185,http://twitter.com/markwatson74/status/434095900848570368,http://twitter.com/markwatson74
02/14/14,http://twitter.com/dawnka/status/434118624727814144,dawnka,"RT @DanaFarber: In a recent webcast, Dr. Ann Lacasce talks about potential for newly approved #ibrutinib (@ 12:50 mark) http://t.co/kngZQcY…",10.400728,http://twitter.com/DawnKA/status/434118624727814144,http://twitter.com/dawnka
02/14/14,http://twitter.com/hannahmcginnis/status/434431549438566400,hannahmcginnis,New post: Medals 4 the best (#worst) things people said during cancer #lymsm #WhatintheWorldAreYouDoingwithCancer http://t.co/kd1RwjUTKW,8.5669155,http://twitter.com/HannahMcGinnis/status/434431549438566400,http://twitter.com/hannahmcginnis
02/14/14,http://twitter.com/healthorder/status/434441474131132416,healthorder,RT @HannahMcGinnis: New post: Medals 4 the best (#worst) things people said during cancer #lymsm #WhatintheWorldAreYouDoingwithCancer http:…,7.5325775,http://twitter.com/healthorder/status/434441474131132416,http://twitter.com/healthorder
02/17/14,http://twitter.com/talkabouthealth/status/435215841743740929,talkabouthealth,How is it determined that the type of #lymphoma is a diffuse large b-cell lymphoma?Dr.Westin @MDAndersonNews http://t.co/g00C8g3Iek #lymsm,11.20071,http://twitter.com/talkabouthealth/status/435215841743740929,http://twitter.com/talkabouthealth
02/17/14,http://twitter.com/healthorder/status/435217277634744320,healthorder,RT @talkabouthealth: How is it determined that the type of #lymphoma is a diffuse large b-cell lymphoma?Dr.Westin @MDAndersonNews http://t.…,7.061942,http://twitter.com/healthorder/status/435217277634744320,http://twitter.com/healthorder
02/18/14,http://twitter.com/drmiguelperales/status/435756915767787522,drmiguelperales,#MSK @ #BMTTandem14 Aethera Trial: Ph3 of Brentuximab Vedotin in pts w Hodgkin Lymphoma after autoSCT http://t.co/QsuMc8zUKd #bmtsm #lymsm,7.615534,http://twitter.com/DrMiguelPerales/status/435756915767787522,http://twitter.com/drmiguelperales
02/18/14,http://twitter.com/drmiguelperales/status/435760694424637440,drmiguelperales,#MSK @ #BMTTandem14 RIC Allo-NCT for Rel/Refr Mantle Cell Lymphoma http://t.co/BiIaitHyD2 #bmtsm #lymsm @albertomussetti,9.250563,http://twitter.com/DrMiguelPerales/status/435760694424637440,http://twitter.com/drmiguelperales
02/18/14,http://twitter.com/albertomussetti/status/435762986561437696,albertomussetti,RT @DrMiguelPerales: #MSK @ #BMTTandem14 RIC Allo-NCT for Rel/Refr Mantle Cell Lymphoma http://t.co/BiIaitHyD2 #bmtsm #lymsm @albertomusset…,6.7166166,http://twitter.com/albertomussetti/status/435762986561437696,http://twitter.com/albertomussetti
02/18/14,http://twitter.com/mskhemonctrials/status/435771514533998592,mskhemonctrials,RT @DrMiguelPerales: #MSK @ #BMTTandem14 RIC Allo-NCT for Rel/Refr Mantle Cell Lymphoma http://t.co/BiIaitHyD2 #bmtsm #lymsm @albertomusset…,6.7166166,http://twitter.com/MSKHemOncTrials/status/435771514533998592,http://twitter.com/mskhemonctrials
02/18/14,http://twitter.com/mskhemonctrials/status/435771661988954112,mskhemonctrials,RT @DrMiguelPerales: #MSK @ #BMTTandem14 Aethera Trial: Ph3 of Brentuximab Vedotin in pts w Hodgkin Lymphoma after autoSCT http://t.co/QsuM…,6.5543437,http://twitter.com/MSKHemOncTrials/status/435771661988954112,http://twitter.com/mskhemonctrials
02/18/14,http://twitter.com/drmarkham/status/435884898550026241,drmarkham,Nice! MT @MaurerStats: DLBCL pts in remission 2 years have same survival as age/sex matched gen population  http://t.co/4TCAruR2a2 #lymsm,11.161429,http://twitter.com/DrMarkham/status/435884898550026241,http://twitter.com/drmarkham
02/18/14,http://twitter.com/healthorder/status/435889870360571905,healthorder,RT @DrMarkham: Nice! MT @MaurerStats: DLBCL pts in remission 2 years have same survival as age/sex matched gen population  http://t.co/4TCA…,7.1524577,http://twitter.com/healthorder/status/435889870360571905,http://twitter.com/healthorder
02/19/14,http://twitter.com/mtmdphd/status/436236393300623362,mtmdphd,Large B-Cell Lymphoma: Reassuring News for Patients in Remission at 2 Years http://t.co/hH36mGaY9Z @MaurerStats #ASCOConnection #lymsm,11.098504,http://twitter.com/mtmdphd/status/436236393300623362,http://twitter.com/mtmdphd
02/19/14,http://twitter.com/healthorder/status/436237222032187392,healthorder,RT @mtmdphd: Large B-Cell Lymphoma: Reassuring News for Patients in Remission at 2 Years http://t.co/hH36mGaY9Z @MaurerStats #ASCOConnectio…,6.993791,http://twitter.com/healthorder/status/436237222032187392,http://twitter.com/healthorder
02/19/14,http://twitter.com/mtmdphd/status/436246369893101568,mtmdphd,24 mon EFS Is a Robust End Pt for Disease-Related Outcome in DLBCL - @MauerStats et al. #JCO http://t.co/oRUxpfB6ES #lymsm,10.856858,http://twitter.com/mtmdphd/status/436246369893101568,http://twitter.com/mtmdphd
02/19/14,http://twitter.com/healthorder/status/436249637755035648,healthorder,RT @mtmdphd: 24 mon EFS Is a Robust End Pt for Disease-Related Outcome in DLBCL - @MauerStats et al. #JCO http://t.co/oRUxpfB6ES #lymsm,6.864813,http://twitter.com/healthorder/status/436249637755035648,http://twitter.com/healthorder
02/20/14,http://twitter.com/drmiguelperales/status/436355188987666432,drmiguelperales,"SAR3419, Anti-CD19 Antibody drug conjugate (ADC), safe and active in Rel/Refr B-cell NHL - Ph1 results http://t.co/U5Sd2W4yAT #lymsm",8.570301,http://twitter.com/DrMiguelPerales/status/436355188987666432,http://twitter.com/drmiguelperales
02/20/14,http://twitter.com/healthorder/status/436356755036311552,healthorder,"RT @DrMiguelPerales: SAR3419, Anti-CD19 Antibody drug conjugate (ADC), safe and active in Rel/Refr B-cell NHL - Ph1 results http://t.co/U5S…",6.5243015,http://twitter.com/healthorder/status/436356755036311552,http://twitter.com/healthorder
02/20/14,http://twitter.com/nextgen_ltd/status/436366674619822080,nextgen_ltd,"RT @DrMiguelPerales: SAR3419, Anti-CD19 Antibody drug conjugate (ADC), safe and active in Rel/Refr B-cell NHL - Ph1 results http://t.co/U5S…",6.5243015,http://twitter.com/NextGEN_Ltd/status/436366674619822080,http://twitter.com/nextgen_ltd
02/20/14,http://twitter.com/j_jay_z/status/436390479668977664,j_jay_z,"RT @DrMiguelPerales: SAR3419, Anti-CD19 Antibody drug conjugate (ADC), safe and active in Rel/Refr B-cell NHL - Ph1 results http://t.co/U5S…",6.5243015,http://twitter.com/j_jay_z/status/436390479668977664,http://twitter.com/j_jay_z
02/20/14,http://twitter.com/eaonc/status/436533376728989696,eaonc,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/vWNPrmxBmb #EAOnc,7.0215883,http://twitter.com/eaonc/status/436533376728989696,http://twitter.com/eaonc
02/20/14,http://twitter.com/talkabouthealth/status/436592185316634624,talkabouthealth,"What are most common places for diffuse large b-cell lymphoma to spread in the body?
Dr.Westin @MDAndersonNews http://t.co/j4trMsT8mh #lymsm",11.981254,http://twitter.com/talkabouthealth/status/436592185316634624,http://twitter.com/talkabouthealth
02/20/14,http://twitter.com/mtmdphd/status/436593804242849792,mtmdphd,Rituximab Active in Nodular Lymphocyte–Predominant Hodgkin Lymphoma - @ASCOPost http://t.co/OsW9Howshw #lymsm,10.209002,http://twitter.com/mtmdphd/status/436593804242849792,http://twitter.com/mtmdphd
02/20/14,http://twitter.com/stromyf/status/436598661477179392,stromyf,"RT @talkabouthealth: What are most common places for diffuse large b-cell lymphoma to spread in the body?
Dr.Westin @MDAndersonNews http://…",7.097801,http://twitter.com/stromyf/status/436598661477179392,http://twitter.com/stromyf
02/20/14,http://twitter.com/blestbutstrest/status/436617904298020865,blestbutstrest,"RT @talkabouthealth: What are most common places for diffuse large b-cell lymphoma to spread in the body?
Dr.Westin @MDAndersonNews http://…",7.097801,http://twitter.com/blestbutstrest/status/436617904298020865,http://twitter.com/blestbutstrest
02/20/14,http://twitter.com/mtmdphd/status/436632653249662976,mtmdphd,Suboptimal dosing of rituximab in male and female patients with DLBCL - Pfreundschuh et al. http://t.co/hyZfLdt792 #lymsm,11.375623,http://twitter.com/mtmdphd/status/436632653249662976,http://twitter.com/mtmdphd
02/20/14,http://twitter.com/healthorder/status/436635899246694400,healthorder,RT @mtmdphd: Suboptimal dosing of rituximab in male and female patients with DLBCL - Pfreundschuh et al. http://t.co/hyZfLdt792 #lymsm,6.9571342,http://twitter.com/healthorder/status/436635899246694400,http://twitter.com/healthorder
02/21/14,http://twitter.com/drmiguelperales/status/436683106817683456,drmiguelperales,No prognostic value for pre-HCT PET Scan in chemosens NHL pts undergoing NMA alloHCT by @DrCraigSauter http://t.co/qgVPhkLSXi #bmtsm #lymsm,8.38537,http://twitter.com/DrMiguelPerales/status/436683106817683456,http://twitter.com/drmiguelperales
02/21/14,http://twitter.com/healthorder/status/436687106522750976,healthorder,RT @DrMiguelPerales: No prognostic value for pre-HCT PET Scan in chemosens NHL pts undergoing NMA alloHCT by @DrCraigSauter http://t.co/qgV…,6.584844,http://twitter.com/healthorder/status/436687106522750976,http://twitter.com/healthorder
02/21/14,http://twitter.com/gioann72/status/436739948205854720,gioann72,RT @DrMiguelPerales: No prognostic value for pre-HCT PET Scan in chemosens NHL pts undergoing NMA alloHCT by @DrCraigSauter http://t.co/qgV…,6.584844,http://twitter.com/gioann72/status/436739948205854720,http://twitter.com/gioann72
02/21/14,http://twitter.com/adc_drugs/status/436782894280089600,adc_drugs,"RT @DrMiguelPerales: SAR3419, Anti-CD19 Antibody drug conjugate (ADC), safe and active in Rel/Refr B-cell NHL - Ph1 results http://t.co/U5S…",6.5243015,http://twitter.com/ADC_drugs/status/436782894280089600,http://twitter.com/adc_drugs
02/21/14,http://twitter.com/timfenske/status/436858559410618369,timfenske,RT @DrMiguelPerales: No prognostic value for pre-HCT PET Scan in chemosens NHL pts undergoing NMA alloHCT by @DrCraigSauter http://t.co/qgV…,6.584844,http://twitter.com/timfenske/status/436858559410618369,http://twitter.com/timfenske
02/21/14,http://twitter.com/talkabouthealth/status/436896445430374400,talkabouthealth,"Refractory diffuse large b-cell #lymphoma not responding to R-CHOP,what is next?Dr.Westin @MDAndersonNews http://t.co/yLh1MzDp6w #lymsm",11.333473,http://twitter.com/talkabouthealth/status/436896445430374400,http://twitter.com/talkabouthealth
02/21/14,http://twitter.com/healthorder/status/436899363177398272,healthorder,"RT @talkabouthealth: Refractory diffuse large b-cell #lymphoma not responding to R-CHOP,what is next?Dr.Westin @MDAndersonNews http://t.co/…",6.7690716,http://twitter.com/healthorder/status/436899363177398272,http://twitter.com/healthorder
02/21/14,http://twitter.com/talkabouthealth/status/436954579465281536,talkabouthealth,What is meaning if my doctor says my diffuse large b-cell #lymphoma is localized?Dr.Westin @MDAndersonNews http://t.co/f0390GhhKA #lymsm,11.2150345,http://twitter.com/talkabouthealth/status/436954579465281536,http://twitter.com/talkabouthealth
02/21/14,http://twitter.com/glenmjones/status/436965388279357440,glenmjones,RT @talkabouthealth: What is meaning if my doctor says my diffuse large b-cell #lymphoma is localized?Dr.Westin @MDAndersonNews http://t.co…,7.0574393,http://twitter.com/glenmjones/status/436965388279357440,http://twitter.com/glenmjones
02/21/14,http://twitter.com/glenmjones/status/437009731899891712,glenmjones,"RT @talkabouthealth: Refractory diffuse large b-cell #lymphoma not responding to R-CHOP,what is next?Dr.Westin @MDAndersonNews http://t.co/…",6.7690716,http://twitter.com/glenmjones/status/437009731899891712,http://twitter.com/glenmjones
02/22/14,http://twitter.com/fischmd/status/437355334290927616,fischmd,"MT @Lymphoma_Doc: If monocytes outnumber lymphocytes during R-CHOP count recovery, worse #lymphoma outcomes http://t.co/cylgaaSkQM #lymsm",11.712942,http://twitter.com/fischmd/status/437355334290927616,http://twitter.com/fischmd
02/22/14,http://twitter.com/timallenmdjd/status/437355740794089472,timallenmdjd,"RT @fischmd: MT @Lymphoma_Doc: If monocytes outnumber lymphocytes during R-CHOP count recovery, worse #lymphoma outcomes http://t.co/cylgaa…",10.057203,http://twitter.com/TimAllenMDJD/status/437355740794089472,http://twitter.com/timallenmdjd
02/22/14,http://twitter.com/drhedrick/status/437355911158702081,drhedrick,"RT @fischmd: MT @Lymphoma_Doc: If monocytes outnumber lymphocytes during R-CHOP count recovery, worse #lymphoma outcomes http://t.co/cylgaa…",6.871543,http://twitter.com/DrHedrick/status/437355911158702081,http://twitter.com/drhedrick
02/23/14,http://twitter.com/alhamrasnights/status/437488817256554496,alhamrasnights,"RT @fischmd: MT @Lymphoma_Doc: If monocytes outnumber lymphocytes during R-CHOP count recovery, worse #lymphoma outcomes http://t.co/cylgaa…",6.871543,http://twitter.com/alhamrasnights/status/437488817256554496,http://twitter.com/alhamrasnights
02/24/14,http://twitter.com/mtmdphd/status/437787963846819841,mtmdphd,Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders @MSKHemOncTrials http://t.co/v6v6O9lpaj #mmsm #lymsm,10.254924,http://twitter.com/mtmdphd/status/437787963846819841,http://twitter.com/mtmdphd
02/24/14,http://twitter.com/mtmdphd/status/437788627494780928,mtmdphd,"Family Study of Lymphoproliferative Disorders - NCT00626496 - @MayoClinic http://t.co/3zGDIpet61 
#leusm #lymsm #mmsm",10.142763,http://twitter.com/mtmdphd/status/437788627494780928,http://twitter.com/mtmdphd
02/24/14,http://twitter.com/drmiguelperales/status/438064471051730944,drmiguelperales,#BMTCTNSOSS Lymphoma prop3 new design for MCL AutoSCT with randomized ibrutinib maintenance #bmtsm #lymsm,6.9203453,http://twitter.com/DrMiguelPerales/status/438064471051730944,http://twitter.com/drmiguelperales
02/24/14,http://twitter.com/mpasca/status/438065219395280896,mpasca,Maintenance as a theme again for #lymsm in #BMTCTNSOSS,8.837098,http://twitter.com/mpasca/status/438065219395280896,http://twitter.com/mpasca
02/25/14,http://twitter.com/rachelgerst/status/438128160782430210,rachelgerst,RT @mtmdphd: Suboptimal dosing of rituximab in male and female patients with DLBCL - Pfreundschuh et al. http://t.co/hyZfLdt792 #lymsm,6.9571342,http://twitter.com/rachelgerst/status/438128160782430210,http://twitter.com/rachelgerst
02/25/14,http://twitter.com/timfenske/status/438406578824163328,timfenske,RT @DrMiguelPerales: #MSK @ #BMTTandem14 RIC Allo-NCT for Rel/Refr Mantle Cell Lymphoma http://t.co/BiIaitHyD2 #bmtsm #lymsm @albertomusset…,6.7166166,http://twitter.com/timfenske/status/438406578824163328,http://twitter.com/timfenske
02/26/14,http://twitter.com/mpasca/status/438708501435539456,mpasca,Just hung the poster (232) #BMTTandem2014 on Bu vs BEAM inAuto #transplants for #lymsm http://t.co/nsjlvw1OQd,8.22317,http://twitter.com/mpasca/status/438708501435539456,http://twitter.com/mpasca
03/01/14,http://twitter.com/eaonc/status/439793512096485376,eaonc,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/7SqgGUvYZf #EAOnc,6.9690485,http://twitter.com/eaonc/status/439793512096485376,http://twitter.com/eaonc
03/01/14,http://twitter.com/glenmjones/status/439828040336814081,glenmjones,"RT @talkabouthealth: What are most common places for diffuse large b-cell lymphoma to spread in the body?
Dr.Westin @MDAndersonNews http://…",7.097801,http://twitter.com/glenmjones/status/439828040336814081,http://twitter.com/glenmjones
03/04/14,http://twitter.com/mtmdphd/status/440639518199521280,mtmdphd,R-GCVP Regimen for Patients With Diffuse Large B-Cell Lymphoma and Cardiac Comorbidity - @ASCOPost http://t.co/1SSsjNRfG8 #lymsm,10.67362,http://twitter.com/mtmdphd/status/440639518199521280,http://twitter.com/mtmdphd
03/04/14,http://twitter.com/drmiguelperales/status/440686177226461184,drmiguelperales,CR rate for 1st-line bendamustine/rituximab noninferior to RCHOP or RCVP in indolent NHL or MCL http://t.co/KQsz8uNoQV #lymsm,7.634306,http://twitter.com/DrMiguelPerales/status/440686177226461184,http://twitter.com/drmiguelperales
03/04/14,http://twitter.com/j_jay_z/status/440709376803090432,j_jay_z,RT @DrMiguelPerales: CR rate for 1st-line bendamustine/rituximab noninferior to RCHOP or RCVP in indolent NHL or MCL http://t.co/KQsz8uNoQV…,6.671601,http://twitter.com/j_jay_z/status/440709376803090432,http://twitter.com/j_jay_z
03/04/14,http://twitter.com/gioann72/status/440729065667182592,gioann72,RT @mtmdphd: R-GCVP Regimen for Patients With Diffuse Large B-Cell Lymphoma and Cardiac Comorbidity - @ASCOPost http://t.co/1SSsjNRfG8 #lym…,6.7013803,http://twitter.com/gioann72/status/440729065667182592,http://twitter.com/gioann72
03/05/14,http://twitter.com/asco/status/441222714939166721,asco,@UChicago's Sonali Smith MD reviews progress against #lymphoma http://t.co/6JXeFjk6Bv (VIDEO) #lymsm,10.966562,http://twitter.com/ASCO/status/441222714939166721,http://twitter.com/asco
03/05/14,http://twitter.com/mtmdphd/status/441293342744514560,mtmdphd,Prevalence &amp; Clinical Implications of Epstein-Barr Virus Infection in de novo DLBCL in Western Countries. CCR http://t.co/RmtXOwfq7i #lymsm,10.285319,http://twitter.com/mtmdphd/status/441293342744514560,http://twitter.com/mtmdphd
03/07/14,http://twitter.com/support_jill/status/442007349717655552,support_jill,Join us at the #Lymphoma Survivorship Conference in Milwaukee April 5th http://t.co/0YI2wKrlky @LLSusa @MedicalCollege #lymsm,8.138978,http://twitter.com/Support_Jill/status/442007349717655552,http://twitter.com/support_jill
03/07/14,http://twitter.com/drmiguelperales/status/442067203593371648,drmiguelperales,Cutaneous T Cell Lymphoma expresses immunosuppressive cell surface protein CD80. Potential therap target? http://t.co/G6hyeUXlXt #lymsm,8.348719,http://twitter.com/DrMiguelPerales/status/442067203593371648,http://twitter.com/drmiguelperales
03/08/14,http://twitter.com/tanjahak/status/442203230043648000,tanjahak,RT @DrMiguelPerales: Cutaneous T Cell Lymphoma expresses immunosuppressive cell surface protein CD80. Potential therap target? http://t.co/…,6.9151797,http://twitter.com/tanjahak/status/442203230043648000,http://twitter.com/tanjahak
03/11/14,http://twitter.com/nextgen_ltd/status/443264791407521792,nextgen_ltd,RT @DrMiguelPerales: Cutaneous T Cell Lymphoma expresses immunosuppressive cell surface protein CD80. Potential therap target? http://t.co/…,6.9151797,http://twitter.com/NextGEN_Ltd/status/443264791407521792,http://twitter.com/nextgen_ltd
03/11/14,http://twitter.com/drmiguelperales/status/443354446521569280,drmiguelperales,How I treat the peripheral T cell lymphomas by @sloan_kettering colleagues #lymsm #bloodjournal http://t.co/225VLv4Foh,11.2982645,http://twitter.com/DrMiguelPerales/status/443354446521569280,http://twitter.com/drmiguelperales
03/11/14,http://twitter.com/drmiguelperales/status/443355250104496128,drmiguelperales,"3 studies of Idelalisib in CLL, MCL, NHL #BloodJournal http://t.co/tEWhyczQn7 http://t.co/Y4vF7XfC4e http://t.co/UirbtTNBUz #lymsm",9.837141,http://twitter.com/DrMiguelPerales/status/443355250104496128,http://twitter.com/drmiguelperales
03/11/14,http://twitter.com/sloan_kettering/status/443389719179972608,sloan_kettering,RT @DrMiguelPerales: How I treat the peripheral T cell lymphomas by @sloan_kettering colleagues #lymsm #bloodjournal http://t.co/225VLv4Foh,10.434913,http://twitter.com/sloan_kettering/status/443389719179972608,http://twitter.com/sloan_kettering
03/11/14,http://twitter.com/wealthmds/status/443443282639876096,wealthmds,RT @Support_Jill: Join us at the #Lymphoma Survivorship Conference in Milwaukee April 5th http://t.co/0YI2wKrlky @LLSusa @MedicalCollege #l…,7.0917277,http://twitter.com/WealthMDs/status/443443282639876096,http://twitter.com/wealthmds
03/11/14,http://twitter.com/transplant_doc/status/443459404289949696,transplant_doc,"RT @DrMiguelPerales: 3 studies of Idelalisib in CLL, MCL, NHL #BloodJournal http://t.co/tEWhyczQn7 http://t.co/Y4vF7XfC4e http://t.co/Uirbt…",7.2412753,http://twitter.com/Transplant_Doc/status/443459404289949696,http://twitter.com/transplant_doc
03/11/14,http://twitter.com/nancylabastida/status/443505144609509376,nancylabastida,RT @mpasca: Just hung the poster (232) #BMTTandem2014 on Bu vs BEAM inAuto #transplants for #lymsm http://t.co/nsjlvw1OQd,7.3262362,http://twitter.com/NancyLabastida/status/443505144609509376,http://twitter.com/nancylabastida
03/12/14,http://twitter.com/psufan1995/status/443546485519818753,psufan1995,"RT @DrMiguelPerales: 3 studies of Idelalisib in CLL, MCL, NHL #BloodJournal http://t.co/tEWhyczQn7 http://t.co/Y4vF7XfC4e http://t.co/Uirbt…",7.2412753,http://twitter.com/psufan1995/status/443546485519818753,http://twitter.com/psufan1995
03/12/14,http://twitter.com/hangoker/status/443658235275649024,hangoker,"RT @DrMiguelPerales: 3 studies of Idelalisib in CLL, MCL, NHL #BloodJournal http://t.co/tEWhyczQn7 http://t.co/Y4vF7XfC4e http://t.co/Uirbt…",7.2412753,http://twitter.com/hangoker/status/443658235275649024,http://twitter.com/hangoker
03/12/14,http://twitter.com/drmiguelperales/status/443729122401845249,drmiguelperales,Sustained CR in pts w lymphoma receiving autologous Cytotoxic T Lymphocytes targeting EBV http://t.co/oofY0eX4Y9 #lymsm,12.23521,http://twitter.com/DrMiguelPerales/status/443729122401845249,http://twitter.com/drmiguelperales
03/12/14,http://twitter.com/healthorder/status/443730472301252608,healthorder,RT @DrMiguelPerales: Sustained CR in pts w lymphoma receiving autologous Cytotoxic T Lymphocytes targeting EBV http://t.co/oofY0eX4Y9 #lymsm,7.0962014,http://twitter.com/healthorder/status/443730472301252608,http://twitter.com/healthorder
03/12/14,http://twitter.com/dockeith/status/443759271289700352,dockeith,One study estimates blood cancers will increase in incidence from 45-57% by the year 2030.  #mmsm #lymsm #leusm @gatewaylls @gatewaytnt,9.889187,http://twitter.com/DocKeith/status/443759271289700352,http://twitter.com/dockeith
03/12/14,http://twitter.com/healthorder/status/443759601029484544,healthorder,RT @DocKeith: One study estimates blood cancers will increase in incidence from 45-57% by the year 2030.  #mmsm #lymsm #leusm @gatewaylls @…,6.639963,http://twitter.com/healthorder/status/443759601029484544,http://twitter.com/healthorder
03/12/14,http://twitter.com/gatewaylls/status/443766590354755584,gatewaylls,RT @DocKeith: One study estimates blood cancers will increase in incidence from 45-57% by the year 2030.  #mmsm #lymsm #leusm @gatewaylls @…,6.639963,http://twitter.com/GatewayLLS/status/443766590354755584,http://twitter.com/gatewaylls
03/12/14,http://twitter.com/gatewaytnt/status/443766745145556992,gatewaytnt,RT @DocKeith: One study estimates blood cancers will increase in incidence from 45-57% by the year 2030.  #mmsm #lymsm #leusm @gatewaylls @…,6.639963,http://twitter.com/GatewayTNT/status/443766745145556992,http://twitter.com/gatewaytnt
03/12/14,http://twitter.com/llsbunny/status/443766844571537408,llsbunny,RT @DocKeith: One study estimates blood cancers will increase in incidence from 45-57% by the year 2030.  #mmsm #lymsm #leusm @gatewaylls @…,6.639963,http://twitter.com/LLSBunny/status/443766844571537408,http://twitter.com/llsbunny
03/12/14,http://twitter.com/arkansaslls/status/443766960791506946,arkansaslls,RT @DocKeith: One study estimates blood cancers will increase in incidence from 45-57% by the year 2030.  #mmsm #lymsm #leusm @gatewaylls @…,6.639963,http://twitter.com/ArkansasLLS/status/443766960791506946,http://twitter.com/arkansaslls
03/12/14,http://twitter.com/kwahl31/status/443767250613719040,kwahl31,RT @DocKeith: One study estimates blood cancers will increase in incidence from 45-57% by the year 2030.  #mmsm #lymsm #leusm @gatewaylls @…,6.639963,http://twitter.com/Kwahl31/status/443767250613719040,http://twitter.com/kwahl31
03/12/14,http://twitter.com/dranasyounes/status/443796735782309888,dranasyounes,RT @DrMiguelPerales: Sustained CR in pts w lymphoma receiving autologous Cytotoxic T Lymphocytes targeting EBV http://t.co/oofY0eX4Y9 #lymsm,10.405872,http://twitter.com/DrAnasYounes/status/443796735782309888,http://twitter.com/dranasyounes
03/12/14,http://twitter.com/adrianabello/status/443804766708465665,adrianabello,RT @DrMiguelPerales: Sustained CR in pts w lymphoma receiving autologous Cytotoxic T Lymphocytes targeting EBV http://t.co/oofY0eX4Y9 #lymsm,7.0962014,http://twitter.com/adrianabello/status/443804766708465665,http://twitter.com/adrianabello
03/12/14,http://twitter.com/mtmdphd/status/443863240872062976,mtmdphd,Rituximab Maintenance Delays Need for Subsequent Txt vs Obs in Asymptomatic Nonbulky Follicular NHL. @ASCOPost http://t.co/ZMVWUk2Dgw #lymsm,10.882247,http://twitter.com/mtmdphd/status/443863240872062976,http://twitter.com/mtmdphd
03/12/14,http://twitter.com/mtmdphd/status/443864193847271424,mtmdphd,"Rituximab vs observ in advanced-stage, asymptomatic, non-bulky follicular NHL - Ardeshna et al. @TheLancetOnc http://t.co/yNc9X4v775 #lymsm",11.006967,http://twitter.com/mtmdphd/status/443864193847271424,http://twitter.com/mtmdphd
03/12/14,http://twitter.com/healthorder/status/443864373770350592,healthorder,RT @mtmdphd: Rituximab Maintenance Delays Need for Subsequent Txt vs Obs in Asymptomatic Nonbulky Follicular NHL. @ASCOPost http://t.co/ZMV…,6.905067,http://twitter.com/healthorder/status/443864373770350592,http://twitter.com/healthorder
03/12/14,http://twitter.com/healthorder/status/443864383853449216,healthorder,"RT @mtmdphd: Rituximab vs observ in advanced-stage, asymptomatic, non-bulky follicular NHL - Ardeshna et al. @TheLancetOnc http://t.co/yNc9…",6.595796,http://twitter.com/healthorder/status/443864383853449216,http://twitter.com/healthorder
03/13/14,http://twitter.com/drmiguelperales/status/444105570363002880,drmiguelperales,PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma — NEJM http://t.co/GJsma2eK0h #lymsm,8.360926,http://twitter.com/DrMiguelPerales/status/444105570363002880,http://twitter.com/drmiguelperales
03/13/14,http://twitter.com/drmiguelperales/status/444105673454780417,drmiguelperales,Idelalisib — A PI3Kδ Inhibitor for B-Cell Cancers — NEJM http://t.co/59cWAXSFkz #lymsm,7.790209,http://twitter.com/DrMiguelPerales/status/444105673454780417,http://twitter.com/drmiguelperales
03/13/14,http://twitter.com/drmiguelperales/status/444105840203550720,drmiguelperales,Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia — @NEJM http://t.co/UzNBEh5Ayw #leusm #lymsm,9.085044,http://twitter.com/DrMiguelPerales/status/444105840203550720,http://twitter.com/drmiguelperales
03/13/14,http://twitter.com/healthorder/status/444106079312805888,healthorder,RT @DrMiguelPerales: PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma — NEJM http://t.co/GJsma2eK0h #lymsm,6.9177713,http://twitter.com/healthorder/status/444106079312805888,http://twitter.com/healthorder
03/13/14,http://twitter.com/gmcrotty/status/444121322487291904,gmcrotty,RT @DrMiguelPerales: PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma — NEJM http://t.co/GJsma2eK0h #lymsm,6.9177713,http://twitter.com/gmcrotty/status/444121322487291904,http://twitter.com/gmcrotty
03/13/14,http://twitter.com/mtmdphd/status/444127147830288384,mtmdphd,Family Study of Lymphoproliferative Disorders - NCT00626496 - @MayoClinic http://t.co/3zGDIpet61#leusm #lymsm #mmsm,10.913261,http://twitter.com/mtmdphd/status/444127147830288384,http://twitter.com/mtmdphd
03/13/14,http://twitter.com/healthorder/status/444128766475108352,healthorder,RT @mtmdphd: Family Study of Lymphoproliferative Disorders - NCT00626496 - @MayoClinic http://t.co/3zGDIpet61#leusm #lymsm #mmsm,6.918299,http://twitter.com/healthorder/status/444128766475108352,http://twitter.com/healthorder
03/13/14,http://twitter.com/lemaistrefred/status/444136497319378945,lemaistrefred,RT @DrMiguelPerales: Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia — @NEJM http://t.co/UzNBEh5Ayw #leusm #lymsm,6.881029,http://twitter.com/LemaistreFred/status/444136497319378945,http://twitter.com/lemaistrefred
03/13/14,http://twitter.com/lemaistrefred/status/444136657496068097,lemaistrefred,RT @DrMiguelPerales: Idelalisib — A PI3Kδ Inhibitor for B-Cell Cancers — NEJM http://t.co/59cWAXSFkz #lymsm,6.815828,http://twitter.com/LemaistreFred/status/444136657496068097,http://twitter.com/lemaistrefred
03/13/14,http://twitter.com/mtmdphd/status/444156679425638401,mtmdphd,Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders@MSKHemOncTrials http://t.co/v6v6O9lpaj #mmsm #lymsm,10.226231,http://twitter.com/mtmdphd/status/444156679425638401,http://twitter.com/mtmdphd
03/13/14,http://twitter.com/hema_news/status/444156737302441984,hema_news,RT @DrMiguelPerales: Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia — @NEJM http://t.co/UzNBEh5Ayw #leusm #lymsm,6.881029,http://twitter.com/Hema_News/status/444156737302441984,http://twitter.com/hema_news
03/14/14,http://twitter.com/eaonc/status/444305705055813632,eaonc,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/HDJmW42wl3 #EAOnc,6.9127927,http://twitter.com/eaonc/status/444305705055813632,http://twitter.com/eaonc
03/16/14,http://twitter.com/mdandersonnews/status/445192860288434176,mdandersonnews,How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,12.987782,http://twitter.com/MDAndersonNews/status/445192860288434176,http://twitter.com/mdandersonnews
03/16/14,http://twitter.com/ahkeenan/status/445193275339988992,ahkeenan,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/ahkeenan/status/445193275339988992,http://twitter.com/ahkeenan
03/16/14,http://twitter.com/elizlincoln/status/445198639087239168,elizlincoln,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/ElizLincoln/status/445198639087239168,http://twitter.com/elizlincoln
03/16/14,http://twitter.com/mikespiziri/status/445234505142394880,mikespiziri,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/mikespiziri/status/445234505142394880,http://twitter.com/mikespiziri
03/16/14,http://twitter.com/cancermedmda/status/445257820665937920,cancermedmda,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/CancerMedMDA/status/445257820665937920,http://twitter.com/cancermedmda
03/16/14,http://twitter.com/oncologyclinics/status/445314665770262528,oncologyclinics,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/OncologyClinics/status/445314665770262528,http://twitter.com/oncologyclinics
03/17/14,http://twitter.com/kevinlewis30/status/445695376327065600,kevinlewis30,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/KevinLewis30/status/445695376327065600,http://twitter.com/kevinlewis30
03/18/14,http://twitter.com/mtmdphd/status/445933519525928960,mtmdphd,Long-Term Follow-Up of R-CHOP + Bevacizumab as Initial Therapy for Mantle Cell Lymphoma - Ruan http://t.co/r937IuDKZc #lymsm,10.778585,http://twitter.com/mtmdphd/status/445933519525928960,http://twitter.com/mtmdphd
03/18/14,http://twitter.com/healthorder/status/445934186843865088,healthorder,RT @mtmdphd: Long-Term Follow-Up of R-CHOP + Bevacizumab as Initial Therapy for Mantle Cell Lymphoma - Ruan http://t.co/r937IuDKZc #lymsm,6.782013,http://twitter.com/healthorder/status/445934186843865088,http://twitter.com/healthorder
03/19/14,http://twitter.com/mtmdphd/status/446407124286205952,mtmdphd,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/o6moHKzw7P #EAOnc,10.839176,http://twitter.com/mtmdphd/status/446407124286205952,http://twitter.com/mtmdphd
03/19/14,http://twitter.com/eaonc/status/446407212056195072,eaonc,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/vhB5nX4rVT #EAOnc,6.895279,http://twitter.com/eaonc/status/446407212056195072,http://twitter.com/eaonc
03/19/14,http://twitter.com/mtmdphd/status/446408400902311936,mtmdphd,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/NHFSQA6d8K #EAOnc,10.016887,http://twitter.com/mtmdphd/status/446408400902311936,http://twitter.com/mtmdphd
03/19/14,http://twitter.com/andreaskleinmd/status/446420406338338816,andreaskleinmd,.@lymphoma NE Lymphoma Rounds #3 introduced by Max Mulcahy - thanks for all the great work you do for #lymphoma patients #lymsm,8.777584,http://twitter.com/AndreasKleinMD/status/446420406338338816,http://twitter.com/andreaskleinmd
03/19/14,http://twitter.com/healthorder/status/446422652648177664,healthorder,RT @AndreasKleinMD: .@lymphoma NE Lymphoma Rounds #3 introduced by Max Mulcahy - thanks for all the great work you do for #lymphoma patient…,7.0012565,http://twitter.com/healthorder/status/446422652648177664,http://twitter.com/healthorder
03/19/14,http://twitter.com/andreaskleinmd/status/446430095147028480,andreaskleinmd,.@lymphoma LRF Lymphoma Rounds: lively debate IT vs HD iv MTX for CNS prophylaxis in NHL - we agree to disagree! #lymsm,7.846375,http://twitter.com/AndreasKleinMD/status/446430095147028480,http://twitter.com/andreaskleinmd
03/19/14,http://twitter.com/healthorder/status/446431438884569089,healthorder,RT @AndreasKleinMD: .@lymphoma LRF Lymphoma Rounds: lively debate IT vs HD iv MTX for CNS prophylaxis in NHL - we agree to disagree! #lymsm,6.821157,http://twitter.com/healthorder/status/446431438884569089,http://twitter.com/healthorder
03/20/14,http://twitter.com/andreaskleinmd/status/446438717063172096,andreaskleinmd,".@lymphoma LRF Boston LR: more spirited debate- ABVD vs CHOP/CVP for NLPHD, but all agree Rituximab goes well with everything. #lymsm",7.682874,http://twitter.com/AndreasKleinMD/status/446438717063172096,http://twitter.com/andreaskleinmd
03/20/14,http://twitter.com/healthorder/status/446440424912470017,healthorder,"RT @AndreasKleinMD: .@lymphoma LRF Boston LR: more spirited debate- ABVD vs CHOP/CVP for NLPHD, but all agree Rituximab goes well with ever…",6.698218,http://twitter.com/healthorder/status/446440424912470017,http://twitter.com/healthorder
03/20/14,http://twitter.com/andreaskleinmd/status/446449754177011712,andreaskleinmd,".@lymphoma Strong finish to Boston LR w facinating and challenging case of coincident HL and EBV - Thanks again, LRF #lymsm",8.029578,http://twitter.com/AndreasKleinMD/status/446449754177011712,http://twitter.com/andreaskleinmd
03/20/14,http://twitter.com/healthorder/status/446451383764783105,healthorder,"RT @AndreasKleinMD: .@lymphoma Strong finish to Boston LR w facinating and challenging case of coincident HL and EBV - Thanks again, LRF #l…",7.10008,http://twitter.com/healthorder/status/446451383764783105,http://twitter.com/healthorder
03/20/14,http://twitter.com/maurerstats/status/446466505199607809,maurerstats,RT @mtmdphd: ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/o6moHKzw7P #EAOnc,6.8037615,http://twitter.com/MaurerStats/status/446466505199607809,http://twitter.com/maurerstats
03/23/14,http://twitter.com/transplant_doc/status/447573279151099904,transplant_doc,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/Transplant_Doc/status/447573279151099904,http://twitter.com/transplant_doc
03/24/14,http://twitter.com/wdlandstx/status/448128835960049665,wdlandstx,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/WdlandsTX/status/448128835960049665,http://twitter.com/wdlandstx
03/24/14,http://twitter.com/mtmdphd/status/448133022584668160,mtmdphd,"MT @FrancescoTurtu1: MYC Expression &amp;/or ""High-grade"" Non-Burkitt DLBCL: #SWOGOnc S9704 http://t.co/SYP8U9pAN8 #lymsm cc: @Kristy_Richards",10.754727,http://twitter.com/mtmdphd/status/448133022584668160,http://twitter.com/mtmdphd
03/24/14,http://twitter.com/healthorder/status/448139784201179136,healthorder,"RT @mtmdphd: MT @FrancescoTurtu1: MYC Expression &amp;/or ""High-grade"" Non-Burkitt DLBCL: #SWOGOnc S9704 http://t.co/SYP8U9pAN8 #lymsm cc: @Kri…",6.7430277,http://twitter.com/healthorder/status/448139784201179136,http://twitter.com/healthorder
03/25/14,http://twitter.com/mtmdphd/status/448469588175757313,mtmdphd,Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/ZLR50JaL02 #lymsm,11.012831,http://twitter.com/mtmdphd/status/448469588175757313,http://twitter.com/mtmdphd
03/25/14,http://twitter.com/subatomicdoc/status/448469724775456768,subatomicdoc,RT @mtmdphd: Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/ZLR50…,10.127381,http://twitter.com/subatomicdoc/status/448469724775456768,http://twitter.com/subatomicdoc
03/25/14,http://twitter.com/curelauncher/status/448502969432952832,curelauncher,RT @MDAndersonNews: How a new treatment is helping #lymphoma and #leukemia patients: http://t.co/ANR0cz6UGa #lymsm #leusm #endcancer,7.219085,http://twitter.com/cureLauncher/status/448502969432952832,http://twitter.com/curelauncher
03/26/14,http://twitter.com/mtmdphd/status/448650641259634688,mtmdphd,Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/GFpY0zuSse  #lymsm,10.80829,http://twitter.com/mtmdphd/status/448650641259634688,http://twitter.com/mtmdphd
03/26/14,http://twitter.com/cancerafrica/status/448653698689155072,cancerafrica,RT @mtmdphd: Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/GFpY0…,6.816244,http://twitter.com/CancerAfrica/status/448653698689155072,http://twitter.com/cancerafrica
03/26/14,http://twitter.com/mtmdphd/status/448812974070050816,mtmdphd,Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/6mSu24jA4w  #lymsm,10.115475,http://twitter.com/mtmdphd/status/448812974070050816,http://twitter.com/mtmdphd
03/26/14,http://twitter.com/mtmdphd/status/448830557368352769,mtmdphd,"Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis &amp; classification - 
Ott et al #ASH13 Ed Bk http://t.co/iN8fONGO2Z #lymsm",10.549546,http://twitter.com/mtmdphd/status/448830557368352769,http://twitter.com/mtmdphd
03/26/14,http://twitter.com/healthorder/status/448832547066507264,healthorder,"RT @mtmdphd: Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis &amp; classification - 
Ott et al #ASH13 Ed Bk http://t.co/iN8f…",6.5797853,http://twitter.com/healthorder/status/448832547066507264,http://twitter.com/healthorder
03/26/14,http://twitter.com/reidnerausani/status/448860860707246080,reidnerausani,"@JaySean Happy Birthday, Mr. Sheezy! There's no words to describe how much you mean to me and to all your Souljas! Enjoy your day! #LYMSM",8.8853035,http://twitter.com/reidnerausani/status/448860860707246080,http://twitter.com/reidnerausani
03/26/14,http://twitter.com/mtmdphd/status/448920654809956352,mtmdphd,Mature Results of a Ph2 Rituximab for Nodular Lymphocyte–Predominant Hodgkin Lymphoma - Advani et al. #JOC http://t.co/062SePNRMP #lymsm,10.63121,http://twitter.com/mtmdphd/status/448920654809956352,http://twitter.com/mtmdphd
03/26/14,http://twitter.com/healthorder/status/448921046792830976,healthorder,RT @mtmdphd: Mature Results of a Ph2 Rituximab for Nodular Lymphocyte–Predominant Hodgkin Lymphoma - Advani et al. #JOC http://t.co/062SePN…,6.5952435,http://twitter.com/healthorder/status/448921046792830976,http://twitter.com/healthorder
03/26/14,http://twitter.com/mtmdphd/status/448937567581659136,mtmdphd,Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/6mSu24jA4w #lymsm,10.802296,http://twitter.com/mtmdphd/status/448937567581659136,http://twitter.com/mtmdphd
03/26/14,http://twitter.com/iamfabiane/status/448941283818868736,iamfabiane,"RT @reidnerausani: @JaySean Happy Birthday, Mr. Sheezy! There's no words to describe how much you mean to me and to all your Souljas! Enjoy…",7.3897166,http://twitter.com/IamFabiane/status/448941283818868736,http://twitter.com/iamfabiane
03/26/14,http://twitter.com/danaholmes911/status/448947473231650816,danaholmes911,RT @mtmdphd: Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/6mSu2…,6.724176,http://twitter.com/DanaHolmes911/status/448947473231650816,http://twitter.com/danaholmes911
03/26/14,http://twitter.com/plmcc54/status/448963965495025665,plmcc54,"Yes! Bone mineral density screening should be routine in lymphoma pts @mtmdphd @Lymphoma_Doc @Annals_Oncology http://t.co/cD2ynKaYyH #lymsm""",8.7460985,http://twitter.com/plmcc54/status/448963965495025665,http://twitter.com/plmcc54
03/26/14,http://twitter.com/farhana_luvzjs/status/448968917692993536,farhana_luvzjs,"RT @reidnerausani: @JaySean Happy Birthday, Mr. Sheezy! There's no words to describe how much you mean to me and to all your Souljas! Enjoy…",7.3897166,http://twitter.com/Farhana_LuvzJS/status/448968917692993536,http://twitter.com/farhana_luvzjs
03/27/14,http://twitter.com/danaholmes911/status/448975945811394560,danaholmes911,RT @plmcc54: Yes! Bone mineral density screening should be routine in lymphoma pts @mtmdphd @Lymphoma_Doc @Annals_Oncology http://t.co/cD2y…,7.005727,http://twitter.com/DanaHolmes911/status/448975945811394560,http://twitter.com/danaholmes911
03/28/14,http://twitter.com/mtmdphd/status/449559208149917696,mtmdphd,Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/5Yxhznu6Gw  #lymsm,11.195685,http://twitter.com/mtmdphd/status/449559208149917696,http://twitter.com/mtmdphd
03/28/14,http://twitter.com/danaholmes911/status/449652317902864384,danaholmes911,RT @mtmdphd: Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/5Yxhz…,6.7806234,http://twitter.com/DanaHolmes911/status/449652317902864384,http://twitter.com/danaholmes911
03/29/14,http://twitter.com/kutzy111/status/449736866011430912,kutzy111,RT @mtmdphd: Bone mineral density screening should be routine in lymphoma Pts - @mtmdphd @Lymphoma_Doc - @Annals_Oncology http://t.co/5Yxhz…,6.7806234,http://twitter.com/kutzy111/status/449736866011430912,http://twitter.com/kutzy111
03/29/14,http://twitter.com/dockeith/status/449941086564139009,dockeith,"Approx every 4 minutes somebody in the U.S is diagnosed with a blood cancer, 1 death every 10 minutes.  #mmsm #leusm #lymsm @GatewayLLS",12.563213,http://twitter.com/DocKeith/status/449941086564139009,http://twitter.com/dockeith
03/29/14,http://twitter.com/healthorder/status/449942493124390914,healthorder,"RT @DocKeith: Approx every 4 minutes somebody in the U.S is diagnosed with a blood cancer, 1 death every 10 minutes.  #mmsm #leusm #lymsm @…",6.9720025,http://twitter.com/healthorder/status/449942493124390914,http://twitter.com/healthorder
03/29/14,http://twitter.com/annhealthcare/status/449944857101230080,annhealthcare,"RT @DocKeith: Approx every 4 minutes somebody in the U.S is diagnosed with a blood cancer, 1 death every 10 minutes.  #mmsm #leusm #lymsm @…",6.9720025,http://twitter.com/AnnHealthCare/status/449944857101230080,http://twitter.com/annhealthcare
03/29/14,http://twitter.com/dockeith/status/449984429469888512,dockeith,"In U. S., men have 1/20 lifetime risk of developing myeloma,  leukemia or lymphoma.   1/25 for women.  @GatewayLLS #mmsm #leusm #lymsm",9.483186,http://twitter.com/DocKeith/status/449984429469888512,http://twitter.com/dockeith
03/29/14,http://twitter.com/healthorder/status/449985080606609408,healthorder,"RT @DocKeith: In U. S., men have 1/20 lifetime risk of developing myeloma,  leukemia or lymphoma.   1/25 for women.  @GatewayLLS #mmsm #leu…",7.026424,http://twitter.com/healthorder/status/449985080606609408,http://twitter.com/healthorder
03/30/14,http://twitter.com/hemedoc/status/450158553626464256,hemedoc,"RT @DocKeith: Approx every 4 minutes somebody in the U.S is diagnosed with a blood cancer, 1 death every 10 minutes.  #mmsm #leusm #lymsm @…",6.9720025,http://twitter.com/hemedoc/status/450158553626464256,http://twitter.com/hemedoc
03/30/14,http://twitter.com/hemedoc/status/450158573100597248,hemedoc,"RT @DocKeith: In U. S., men have 1/20 lifetime risk of developing myeloma,  leukemia or lymphoma.   1/25 for women.  @GatewayLLS #mmsm #leu…",7.026424,http://twitter.com/hemedoc/status/450158573100597248,http://twitter.com/hemedoc
03/30/14,http://twitter.com/drmiguelperales/status/450203037194543104,drmiguelperales,#EBMT2014 Gisselbrecht: Are we moving towards cell of origin therapy in DLBCL? #lymsm,8.145078,http://twitter.com/DrMiguelPerales/status/450203037194543104,http://twitter.com/drmiguelperales
03/30/14,http://twitter.com/drmiguelperales/status/450203053984321536,drmiguelperales,"#EBMT2014 Gisselbrecht: new drugs needed for optimal salvage, cell of origin will guide RX, combinations still backbone of salvage #lymsm",8.097583,http://twitter.com/DrMiguelPerales/status/450203053984321536,http://twitter.com/drmiguelperales
03/30/14,http://twitter.com/healthorder/status/450203601311633408,healthorder,RT @DrMiguelPerales: #EBMT2014 Gisselbrecht: Are we moving towards cell of origin therapy in DLBCL? #lymsm,7.080866,http://twitter.com/healthorder/status/450203601311633408,http://twitter.com/healthorder
03/30/14,http://twitter.com/healthorder/status/450203612896296960,healthorder,"RT @DrMiguelPerales: #EBMT2014 Gisselbrecht: new drugs needed for optimal salvage, cell of origin will guide RX, combinations still backbon…",7.0442085,http://twitter.com/healthorder/status/450203612896296960,http://twitter.com/healthorder
03/30/14,http://twitter.com/drmiguelperales/status/450205227221020672,drmiguelperales,#EBMT2014 Schmitz new study ongoing combining pixantrone and rituximab in rel/refr NHL #lymsm,8.772048,http://twitter.com/DrMiguelPerales/status/450205227221020672,http://twitter.com/drmiguelperales
03/30/14,http://twitter.com/healthorder/status/450206846243315712,healthorder,RT @DrMiguelPerales: #EBMT2014 Schmitz new study ongoing combining pixantrone and rituximab in rel/refr NHL #lymsm,6.9544506,http://twitter.com/healthorder/status/450206846243315712,http://twitter.com/healthorder
03/30/14,http://twitter.com/drmiguelperales/status/450207393549668352,drmiguelperales,#EBMT2014 Anna Sureda discussing role of alloHCT for DLBCL #lymsm #bntsm,8.011583,http://twitter.com/DrMiguelPerales/status/450207393549668352,http://twitter.com/drmiguelperales
03/30/14,http://twitter.com/healthorder/status/450208613404266496,healthorder,RT @DrMiguelPerales: #EBMT2014 Anna Sureda discussing role of alloHCT for DLBCL #lymsm #bntsm,7.0427194,http://twitter.com/healthorder/status/450208613404266496,http://twitter.com/healthorder
03/30/14,http://twitter.com/drmiguelperales/status/450287064764780544,drmiguelperales,#EBMT2014 interesting discussion on role of brentuximab Vedotin in different settings for Hodgkin lymphoma - several studies ongoing #lymsm,7.6461134,http://twitter.com/DrMiguelPerales/status/450287064764780544,http://twitter.com/drmiguelperales
03/30/14,http://twitter.com/healthorder/status/450287391178510337,healthorder,RT @DrMiguelPerales: #EBMT2014 interesting discussion on role of brentuximab Vedotin in different settings for Hodgkin lymphoma - several s…,6.720577,http://twitter.com/healthorder/status/450287391178510337,http://twitter.com/healthorder
03/31/14,http://twitter.com/mtmdphd/status/450450848955785216,mtmdphd,"RT @DocKeith: Approx every 4 minutes somebody in the U.S is diagnosed with a blood cancer, 1 death every 10 minutes.  #mmsm #leusm #lymsm @…",10.158923,http://twitter.com/mtmdphd/status/450450848955785216,http://twitter.com/mtmdphd
03/31/14,http://twitter.com/nlwall/status/450451656660885508,nlwall,"RT @DocKeith: Approx every 4 minutes somebody in the U.S is diagnosed with a blood cancer, 1 death every 10 minutes.  #mmsm #leusm #lymsm @…",6.9720025,http://twitter.com/nlwall/status/450451656660885508,http://twitter.com/nlwall
03/31/14,http://twitter.com/drmiguelperales/status/450584746733879296,drmiguelperales,"Interesting article ""Molecular genetics of peripheral T-cell lymphomas"" #EBMT2014 #lymsm http://t.co/LYTZEHiTTP",9.125252,http://twitter.com/DrMiguelPerales/status/450584746733879296,http://twitter.com/drmiguelperales
03/31/14,http://twitter.com/healthorder/status/450584842108141568,healthorder,"RT @DrMiguelPerales: Interesting article ""Molecular genetics of peripheral T-cell lymphomas"" #EBMT2014 #lymsm http://t.co/LYTZEHiTTP",7.064855,http://twitter.com/healthorder/status/450584842108141568,http://twitter.com/healthorder
03/31/14,http://twitter.com/lymphomahub/status/450585770240528384,lymphomahub,"RT @DrMiguelPerales: Interesting article ""Molecular genetics of peripheral T-cell lymphomas"" #EBMT2014 #lymsm http://t.co/LYTZEHiTTP",7.064855,http://twitter.com/lymphomahub/status/450585770240528384,http://twitter.com/lymphomahub
03/31/14,http://twitter.com/xx3xx39xx/status/450596189394579457,xx3xx39xx,"RT @DrMiguelPerales: Interesting article ""Molecular genetics of peripheral T-cell lymphomas"" #EBMT2014 #lymsm http://t.co/LYTZEHiTTP",7.064855,http://twitter.com/Xx3Xx39xx/status/450596189394579457,http://twitter.com/xx3xx39xx
03/31/14,http://twitter.com/feldstej/status/450596648616751104,feldstej,"RT @DrMiguelPerales: Interesting article ""Molecular genetics of peripheral T-cell lymphomas"" #EBMT2014 #lymsm http://t.co/LYTZEHiTTP",7.064855,http://twitter.com/feldstej/status/450596648616751104,http://twitter.com/feldstej
04/01/14,http://twitter.com/maurerstats/status/450805651107618816,maurerstats,Diagnostic accuracy of a defined IHC &amp; molecular approach for peripheral T/NK cell #lymphoma #lymsm AJSP: http://t.co/8AT4GWAzdL,7.1466985,http://twitter.com/MaurerStats/status/450805651107618816,http://twitter.com/maurerstats
04/02/14,http://twitter.com/drmiguelperales/status/451471728569774081,drmiguelperales,RT @MSKCC_OncoNotes Combination #Brentuximab #Vedotin Therapy in the Management of #Hodgkin #Lymphoma. #lymsm http://t.co/sJ3epf6jW7,7.1551924,http://twitter.com/DrMiguelPerales/status/451471728569774081,http://twitter.com/drmiguelperales
04/04/14,http://twitter.com/cancergeek/status/452066734342963200,cancergeek,"Research: Chemotherapy-free treatment a possibility for leukemia/lymphoma - via @ONA http://t.co/sll2PKqbpM
#research #leusm #lymsm #cancer",7.072699,http://twitter.com/CancerGeek/status/452066734342963200,http://twitter.com/cancergeek
04/04/14,http://twitter.com/drmiguelperales/status/452099539194105856,drmiguelperales,Good to see growing number of #bmtsm MDs on @Twitter - Join the conversation. #leusm #mmsm #lymsm,11.860797,http://twitter.com/DrMiguelPerales/status/452099539194105856,http://twitter.com/drmiguelperales
04/04/14,http://twitter.com/mtmdphd/status/452103908497031168,mtmdphd,RT @DrMiguelPerales: Good to see growing number of #bmtsm MDs on @Twitter - Join the conversation. #leusm #mmsm #lymsm,10.081326,http://twitter.com/mtmdphd/status/452103908497031168,http://twitter.com/mtmdphd
04/04/14,http://twitter.com/lemaistrefred/status/452107035912335361,lemaistrefred,RT @DrMiguelPerales: Good to see growing number of #bmtsm MDs on @Twitter - Join the conversation. #leusm #mmsm #lymsm,6.894404,http://twitter.com/LemaistreFred/status/452107035912335361,http://twitter.com/lemaistrefred
04/04/14,http://twitter.com/danaholmes911/status/452112219778846720,danaholmes911,RT @DrMiguelPerales: Good to see growing number of #bmtsm MDs on @Twitter - Join the conversation. #leusm #mmsm #lymsm,6.894404,http://twitter.com/DanaHolmes911/status/452112219778846720,http://twitter.com/danaholmes911
04/04/14,http://twitter.com/cancertuz/status/452164378918649856,cancertuz,Chemotherapyfree #treatment a possibility for #leukemia/lymphoma http://t.co/y1wvnQ9x66 #cancer #ONA #lymsm #leusm #research #ONAcom,7.209596,http://twitter.com/CancerTuz/status/452164378918649856,http://twitter.com/cancertuz
04/05/14,http://twitter.com/jj_boelens/status/452351625144041472,jj_boelens,RT @DrMiguelPerales: Good to see growing number of #bmtsm MDs on @Twitter - Join the conversation. #leusm #mmsm #lymsm,6.894404,http://twitter.com/JJ_boelens/status/452351625144041472,http://twitter.com/jj_boelens
04/06/14,http://twitter.com/talkabouthealth/status/452912501357686784,talkabouthealth,"For stage 1 follicular #lymphoma what is the typical first line of treatment?@Lymphoma_Doc
 @MDAndersonNews
http://t.co/EnpqSgNqx7 #lymsm",12.430755,http://twitter.com/talkabouthealth/status/452912501357686784,http://twitter.com/talkabouthealth
04/06/14,http://twitter.com/lymphoma_doc/status/452918940688072704,lymphoma_doc,"RT @talkabouthealth: For stage 1 follicular #lymphoma what is the typical first line of treatment?@Lymphoma_Doc
 @MDAndersonNews
http://t.c…",7.1199155,http://twitter.com/Lymphoma_Doc/status/452918940688072704,http://twitter.com/lymphoma_doc
04/06/14,http://twitter.com/adrianabello/status/452919490612043776,adrianabello,"RT @talkabouthealth: For stage 1 follicular #lymphoma what is the typical first line of treatment?@Lymphoma_Doc
 @MDAndersonNews
http://t.c…",7.1199155,http://twitter.com/adrianabello/status/452919490612043776,http://twitter.com/adrianabello
04/06/14,http://twitter.com/timfenske/status/452951243522990080,timfenske,"RT @talkabouthealth: For stage 1 follicular #lymphoma what is the typical first line of treatment?@Lymphoma_Doc
 @MDAndersonNews
http://t.c…",7.1199155,http://twitter.com/timfenske/status/452951243522990080,http://twitter.com/timfenske
04/07/14,http://twitter.com/glenmjones/status/452961703756853248,glenmjones,"RT @talkabouthealth: For stage 1 follicular #lymphoma what is the typical first line of treatment?@Lymphoma_Doc
 @MDAndersonNews
http://t.c…",7.1199155,http://twitter.com/glenmjones/status/452961703756853248,http://twitter.com/glenmjones
04/07/14,http://twitter.com/drmiguelperales/status/453160843975606272,drmiguelperales,Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma #lymsm http://t.co/gIIPhu6kC7,10.943316,http://twitter.com/DrMiguelPerales/status/453160843975606272,http://twitter.com/drmiguelperales
04/07/14,http://twitter.com/mtmdphd/status/453171202648190976,mtmdphd,RT @DrMiguelPerales: Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma #lymsm h…,10.041249,http://twitter.com/mtmdphd/status/453171202648190976,http://twitter.com/mtmdphd
04/07/14,http://twitter.com/drmiguelperales/status/453219334706716673,drmiguelperales,Attending Tri-State Transplant Consortium @sloan_kettering Collaborating w other BMT centers #bmtsm #mmsm #lymsm #leusm,6.9953456,http://twitter.com/DrMiguelPerales/status/453219334706716673,http://twitter.com/drmiguelperales
04/08/14,http://twitter.com/asbmt/status/453528996567719936,asbmt,"New in #BBMT: Phase I/II Study of Bortezomib-BEAM &amp; AutoSCT for Relapsed Indolent NHL, Transformed, or MCL http://t.co/j945uZFywR #lymsm",8.931978,http://twitter.com/ASBMT/status/453528996567719936,http://twitter.com/asbmt
04/08/14,http://twitter.com/drmiguelperales/status/453540494996672512,drmiguelperales,"RT @ASBMT: New in #BBMT: Phase I/II Study of Bortezomib-BEAM &amp; AutoSCT for Relapsed Indolent NHL, Transformed, or MCL http://t.co/j945uZFyw…",6.7064557,http://twitter.com/DrMiguelPerales/status/453540494996672512,http://twitter.com/drmiguelperales
04/09/14,http://twitter.com/drmiguelperales/status/453867368369098752,drmiguelperales,24% discordant results &amp; 11% resulting in Rx change! Referring vs. final path for Tcell NHL in NCCN #lymsm http://t.co/xGSWLtPGgU …,7.764502,http://twitter.com/DrMiguelPerales/status/453867368369098752,http://twitter.com/drmiguelperales
04/09/14,http://twitter.com/zachpharmd/status/453867607960338432,zachpharmd,RT @DrMiguelPerales: 24% discordant results &amp; 11% resulting in Rx change! Referring vs. final path for Tcell NHL in NCCN #lymsm http://t.co…,6.729737,http://twitter.com/ZachPharmD/status/453867607960338432,http://twitter.com/zachpharmd
04/09/14,http://twitter.com/asbmt/status/453900780412473345,asbmt,May issue of #BBMT now available online! http://t.co/SXHwknscNC #bmtsm #mmsm #lymsm #leusm,8.243037,http://twitter.com/ASBMT/status/453900780412473345,http://twitter.com/asbmt
04/09/14,http://twitter.com/drmiguelperales/status/453901504051965953,drmiguelperales,RT @ASBMT: May issue of #BBMT now available online! http://t.co/SXHwknscNC #bmtsm #mmsm #lymsm #leusm,7.205609,http://twitter.com/DrMiguelPerales/status/453901504051965953,http://twitter.com/drmiguelperales
04/10/14,http://twitter.com/mtmdphd/status/454308444925751296,mtmdphd,Enjoying @GregNowakowski presenting on Lymphoma at @Aurora_Health Grand Rounds #lymsm,10.765831,http://twitter.com/mtmdphd/status/454308444925751296,http://twitter.com/mtmdphd
04/10/14,http://twitter.com/mtmdphd/status/454309053536014336,mtmdphd,Lenalidomide in B-cell Malignancy - @GregNowakowski reviewing @AsherChananKhan studies #JCO 2008 #lymsm,10.085168,http://twitter.com/mtmdphd/status/454309053536014336,http://twitter.com/mtmdphd
04/10/14,http://twitter.com/mtmdphd/status/454310287970013184,mtmdphd,Ph2 #EAOnc E1412 RCHOP v R2CHOP DLBCL study discussed via @GregNowakowski http://t.co/FeIzu0bAeS #lymsm #ASH12 Abst 689,9.895907,http://twitter.com/mtmdphd/status/454310287970013184,http://twitter.com/mtmdphd
04/10/14,http://twitter.com/dockeith/status/454363412667977728,dockeith,The incidence of non-Hodgkin's lymphoma in U.S. is expected to increase by 45% between 2010 -2030.  #lymsm  @GatewayLLS @LLSinRI  @LLSusa,8.489391,http://twitter.com/DocKeith/status/454363412667977728,http://twitter.com/dockeith
04/11/14,http://twitter.com/gatewaylls/status/454606388925194240,gatewaylls,RT @DocKeith: The incidence of non-Hodgkin's lymphoma in U.S. is expected to increase by 45% between 2010 -2030.  #lymsm  @GatewayLLS @LLSi…,6.729592,http://twitter.com/GatewayLLS/status/454606388925194240,http://twitter.com/gatewaylls
04/12/14,http://twitter.com/mtmdphd/status/454786099047833600,mtmdphd,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/HLGwpuU4JL #EAOnc,10.783005,http://twitter.com/mtmdphd/status/454786099047833600,http://twitter.com/mtmdphd
04/12/14,http://twitter.com/eaonc/status/454786099014303744,eaonc,ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/zSunE65C2m #EAOnc,7.0222,http://twitter.com/eaonc/status/454786099014303744,http://twitter.com/eaonc
04/12/14,http://twitter.com/marthas61/status/454857173756293120,marthas61,RT @mtmdphd: ECOG-ACRIN Active Clinical Trials - Lymphoma - #lymsm http://t.co/HLGwpuU4JL #EAOnc,6.7909594,http://twitter.com/MarthaS61/status/454857173756293120,http://twitter.com/marthas61
04/14/14,http://twitter.com/talkabouthealth/status/455726210232754176,talkabouthealth,"Daily ans: Advanced diffuse large b-cell #lymphoma,what is typically first treatment?Dr.Westin @Lymphoma_Doc http://t.co/kJrLw22Z5Q #lymsm",11.453448,http://twitter.com/talkabouthealth/status/455726210232754176,http://twitter.com/talkabouthealth
04/15/14,http://twitter.com/mdandersonnews/status/456054790523723776,mdandersonnews,#Lymphoma survivor: “I’m not sad I had #cancer. I’m glad to be a survivor.” http://t.co/utEscguwAt #lymsm #endcancer,13.009931,http://twitter.com/MDAndersonNews/status/456054790523723776,http://twitter.com/mdandersonnews
04/15/14,http://twitter.com/dawnka/status/456057549226528768,dawnka,RT @MDAndersonNews: #Lymphoma survivor: “I’m not sad I had #cancer. I’m glad to be a survivor.” http://t.co/utEscguwAt #lymsm #endcancer,10.798155,http://twitter.com/DawnKA/status/456057549226528768,http://twitter.com/dawnka
04/15/14,http://twitter.com/nocancersa/status/456057567383674880,nocancersa,RT @MDAndersonNews: #Lymphoma survivor: “I’m not sad I had #cancer. I’m glad to be a survivor.” http://t.co/utEscguwAt #lymsm #endcancer,7.577612,http://twitter.com/NoCancerSA/status/456057567383674880,http://twitter.com/nocancersa
04/15/14,http://twitter.com/zhenmahoney/status/456064554028388352,zhenmahoney,RT @MDAndersonNews: #Lymphoma survivor: “I’m not sad I had #cancer. I’m glad to be a survivor.” http://t.co/utEscguwAt #lymsm #endcancer,7.577612,http://twitter.com/ZhenMahoney/status/456064554028388352,http://twitter.com/zhenmahoney
04/15/14,http://twitter.com/eclipsecro/status/456066465528303616,eclipsecro,RT @MDAndersonNews: #Lymphoma survivor: “I’m not sad I had #cancer. I’m glad to be a survivor.” http://t.co/utEscguwAt #lymsm #endcancer,7.577612,http://twitter.com/eClipseCRO/status/456066465528303616,http://twitter.com/eclipsecro
04/15/14,http://twitter.com/mikethompsonx4/status/456069006483398656,mikethompsonx4,RT @MDAndersonNews: #Lymphoma survivor: “I’m not sad I had #cancer. I’m glad to be a survivor.” http://t.co/utEscguwAt #lymsm #endcancer,7.577612,http://twitter.com/mikethompsonx4/status/456069006483398656,http://twitter.com/mikethompsonx4
04/15/14,http://twitter.com/glenmjones/status/456157757758922752,glenmjones,"RT @talkabouthealth: Daily ans: Advanced diffuse large b-cell #lymphoma,what is typically first treatment?Dr.Westin @Lymphoma_Doc http://t.…",6.8389163,http://twitter.com/glenmjones/status/456157757758922752,http://twitter.com/glenmjones
04/17/14,http://twitter.com/asco/status/456780052437270528,asco,Mogamulizumab for CCR4-Positive T-Cell Lymphoma http://t.co/rtGbueEMGZ #JCO #lymsm,11.480509,http://twitter.com/ASCO/status/456780052437270528,http://twitter.com/asco
04/17/14,http://twitter.com/grahamslist/status/456780618974511104,grahamslist,RT @ASCO: Mogamulizumab for CCR4-Positive T-Cell Lymphoma http://t.co/rtGbueEMGZ #JCO #lymsm,6.9102726,http://twitter.com/grahamslist/status/456780618974511104,http://twitter.com/grahamslist
04/17/14,http://twitter.com/florianslimano/status/456783661061660672,florianslimano,RT @ASCO: Mogamulizumab for CCR4-Positive T-Cell Lymphoma http://t.co/rtGbueEMGZ #JCO #lymsm,6.9102726,http://twitter.com/FlorianSlimano/status/456783661061660672,http://twitter.com/florianslimano
03/29/14,http://twitter.com/dockeith/status/449984429469888512,gatewaytnt,"RT @DocKeith: In U. S., men have 1/20 lifetime risk of developing myeloma,  leukemia or lymphoma.   1/25 for women.  @GatewayLLS #mmsm #leu…",8.667729,http://twitter.com/GatewayTNT/status/456840659358715905,http://twitter.com/gatewaytnt
04/17/14,http://twitter.com/llssctx/status/456843738912808961,llssctx,"RT @DocKeith: In U. S., men have 1/20 lifetime risk of developing myeloma,  leukemia or lymphoma.   1/25 for women.  @GatewayLLS #mmsm #leu…",6.9217553,http://twitter.com/LLSSCTX/status/456843738912808961,http://twitter.com/llssctx
04/17/14,http://twitter.com/gatewaylls/status/456860872359813120,gatewaylls,"RT @DocKeith: In U. S., men have 1/20 lifetime risk of developing myeloma,  leukemia or lymphoma.   1/25 for women.  @GatewayLLS #mmsm #leu…",6.9217553,http://twitter.com/GatewayLLS/status/456860872359813120,http://twitter.com/gatewaylls
04/17/14,http://twitter.com/kwahl31/status/456861142879854592,kwahl31,"RT @DocKeith: In U. S., men have 1/20 lifetime risk of developing myeloma,  leukemia or lymphoma.   1/25 for women.  @GatewayLLS #mmsm #leu…",6.9217553,http://twitter.com/Kwahl31/status/456861142879854592,http://twitter.com/kwahl31
04/19/14,http://twitter.com/drmiguelperales/status/457571288379588608,drmiguelperales,"Limited-Stage Hodgkin Lymphoma: Managing Uncertainty, Meyer, R. M. #JCO @ASCO #lymsm http://t.co/hI1LPQXteE",8.132164,http://twitter.com/DrMiguelPerales/status/457571288379588608,http://twitter.com/drmiguelperales
04/19/14,http://twitter.com/9872002685/status/457600693206257664,9872002685,"RT @DrMiguelPerales: Limited-Stage Hodgkin Lymphoma: Managing Uncertainty, Meyer, R. M. #JCO @ASCO #lymsm http://t.co/hI1LPQXteE",7.1379266,http://twitter.com/9872002685/status/457600693206257664,http://twitter.com/9872002685
04/20/14,http://twitter.com/fischmd/status/457902337533943808,fischmd,"Considering #survivorship from the outset, MT @FrancescoTurtu1: Limited-Stage Hodgkin #Lymphoma, JCO http://t.co/mGRJh1gR23 #lymsm",11.136739,http://twitter.com/fischmd/status/457902337533943808,http://twitter.com/fischmd
04/20/14,http://twitter.com/humbertosinco/status/457906372739231744,humbertosinco,"RT @fischmd: Considering #survivorship from the outset, MT @FrancescoTurtu1: Limited-Stage Hodgkin #Lymphoma, JCO http://t.co/mGRJh1gR23 #l…",7.137094,http://twitter.com/humbertosinco/status/457906372739231744,http://twitter.com/humbertosinco
04/23/14,http://twitter.com/mtmdphd/status/458951280053211136,mtmdphd,"MT @FrancescoTurtu1: ‘Double-Hit’ #Lymphoma a Challenge for the Oncologist
http://t.co/eoA55bDWaO #lymsm",10.637477,http://twitter.com/mtmdphd/status/458951280053211136,http://twitter.com/mtmdphd
04/23/14,http://twitter.com/jorunkjones/status/458951465244311552,jorunkjones,"RT @talkabouthealth: Daily ans: Advanced diffuse large b-cell #lymphoma,what is typically first treatment?Dr.Westin @Lymphoma_Doc http://t.…",6.8389163,http://twitter.com/jorunkjones/status/458951465244311552,http://twitter.com/jorunkjones
04/24/14,http://twitter.com/oncnursingnews/status/459373900317851648,oncnursingnews,Attending ONS in Anaheim? Case studies to build your knowledge of blood cancer treatment/prognosis via @LLSusa http://t.co/h1EHQPNvZS #lymsm,7.521753,http://twitter.com/OncNursingNews/status/459373900317851648,http://twitter.com/oncnursingnews
04/25/14,http://twitter.com/hannahmcginnis/status/459483697679323136,hannahmcginnis,"New post up: Why ""Getting Over"" Cancer Isn't A Thing #lymsm #WhatintheWorldAreYouDoingwithCancer 
http://t.co/9TD5Kkbqqw",8.157786,http://twitter.com/HannahMcGinnis/status/459483697679323136,http://twitter.com/hannahmcginnis
04/25/14,http://twitter.com/talkabouthealth/status/459788568588591104,talkabouthealth,What is role of radiation oncology in the treatment of diffuse large b-cell #lymphoma?Dr.Kelsey @DukeCancer http://t.co/QCu4KzxGsl #lymsm,10.635674,http://twitter.com/talkabouthealth/status/459788568588591104,http://twitter.com/talkabouthealth
04/27/14,http://twitter.com/talkabouthealth/status/460440880550117376,talkabouthealth,"Diffuse b-cell #Lymphoma patient having radiation therapy,how do you monitor progress?Dr.Kelsey @DukeCancer
http://t.co/3IGy5IXOjB #lymsm",10.480626,http://twitter.com/talkabouthealth/status/460440880550117376,http://twitter.com/talkabouthealth
04/28/14,http://twitter.com/talkabouthealth/status/460879783950172161,talkabouthealth,"What factors determine the stage of diffuse b-cell #Lymphoma
Dr.Kelsey @DukeCancer
http://t.co/iCBinNVmZq #lymsm",12.041677,http://twitter.com/talkabouthealth/status/460879783950172161,http://twitter.com/talkabouthealth
04/28/14,http://twitter.com/conversantbio/status/460881376892694528,conversantbio,"RT @talkabouthealth: What factors determine the stage of diffuse b-cell #Lymphoma
Dr.Kelsey @DukeCancer
http://t.co/iCBinNVmZq #lymsm",7.0772038,http://twitter.com/ConversantBIO/status/460881376892694528,http://twitter.com/conversantbio
04/28/14,http://twitter.com/glenmjones/status/460912904142065665,glenmjones,"RT @talkabouthealth: What factors determine the stage of diffuse b-cell #Lymphoma
Dr.Kelsey @DukeCancer
http://t.co/iCBinNVmZq #lymsm",7.0772038,http://twitter.com/glenmjones/status/460912904142065665,http://twitter.com/glenmjones
04/29/14,http://twitter.com/drmiguelperales/status/461117782583943168,drmiguelperales,"ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma
#lymsm http://t.co/rAf1LPg9oc",7.1005845,http://twitter.com/DrMiguelPerales/status/461117782583943168,http://twitter.com/drmiguelperales
04/29/14,http://twitter.com/drmiguelperales/status/461122377276223488,drmiguelperales,"Interesting article ""Guidelines for the first line management of classical Hodgkin Lymphoma "" #lymsm http://t.co/F09GPiRI2p",9.393752,http://twitter.com/DrMiguelPerales/status/461122377276223488,http://twitter.com/drmiguelperales
04/29/14,http://twitter.com/drmiguelperales/status/461124779899387904,drmiguelperales,"Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma
#lymsm http://t.co/5wZiBfJ5zI",7.2876883,http://twitter.com/DrMiguelPerales/status/461124779899387904,http://twitter.com/drmiguelperales
04/29/14,http://twitter.com/jorunkjones/status/461141427217760256,jorunkjones,"RT @talkabouthealth: What factors determine the stage of diffuse b-cell #Lymphoma
Dr.Kelsey @DukeCancer
http://t.co/iCBinNVmZq #lymsm",7.0772038,http://twitter.com/jorunkjones/status/461141427217760256,http://twitter.com/jorunkjones
04/29/14,http://twitter.com/citohans/status/461178258986655744,citohans,"RT @DrMiguelPerales: Interesting article ""Guidelines for the first line management of classical Hodgkin Lymphoma "" #lymsm http://t.co/F09GP…",7.6286135,http://twitter.com/citohans/status/461178258986655744,http://twitter.com/citohans
04/30/14,http://twitter.com/mtmdphd/status/461464683346526209,mtmdphd,LS1293 Lymphoma Vit D Replacement Trial @MayoClinic - discussed by @GregNowakowski based on Drake et al. data #lymsm,11.116673,http://twitter.com/mtmdphd/status/461464683346526209,http://twitter.com/mtmdphd
04/30/14,http://twitter.com/mtmdphd/status/461464698894827520,mtmdphd,"Need to personalize DLBCL treatment. Check Myc, Bcl upfront (for double hit). Can't determine by morphology alone. @GregNowakowski #lymsm",10.43647,http://twitter.com/mtmdphd/status/461464698894827520,http://twitter.com/mtmdphd
04/30/14,http://twitter.com/maurerstats/status/461472949799616512,maurerstats,RT @mtmdphd: LS1293 Lymphoma Vit D Replacement Trial @MayoClinic - discussed by @GregNowakowski based on Drake et al. data #lymsm,7.0987034,http://twitter.com/MaurerStats/status/461472949799616512,http://twitter.com/maurerstats
04/30/14,http://twitter.com/talkabouthealth/status/461526057581961217,talkabouthealth,"What does it mean if my diffuse b-cell #lymphoma is 'bulky'? Dr.Kelsey @Duke_Medicine @DukeCancer
http://t.co/14uxQHbLBa #lymsm",10.48579,http://twitter.com/talkabouthealth/status/461526057581961217,http://twitter.com/talkabouthealth
04/30/14,http://twitter.com/oncnursingnews/status/461598514758578176,oncnursingnews,Attending ONS in Anaheim? Case studies to build your knowledge of blood cancer treatment/prognosis via @LLSusa http://t.co/cTwrizt3P5 #lymsm,7.3779454,http://twitter.com/OncNursingNews/status/461598514758578176,http://twitter.com/oncnursingnews
04/30/14,http://twitter.com/mtmdphd/status/461636564918214656,mtmdphd,"Vitamin D may raise survival rates among cancer patients http://t.co/dtouZ9yHtU 
Li et al. JCEM http://t.co/PdcBaJq56u #bcsm #crcsm #lymsm",12.888734,http://twitter.com/mtmdphd/status/461636564918214656,http://twitter.com/mtmdphd
04/30/14,http://twitter.com/lungcanetwork/status/461638493752819712,lungcanetwork,"RT @mtmdphd: Vitamin D may raise survival rates among cancer patients http://t.co/dtouZ9yHtU 
Li et al. JCEM http://t.co/PdcBaJq56u #bcsm #…",7.155776,http://twitter.com/LungCaNetwork/status/461638493752819712,http://twitter.com/lungcanetwork
05/01/14,http://twitter.com/hcaoncnursenav/status/461681250571653120,hcaoncnursenav,"RT @mtmdphd: Vitamin D may raise survival rates among cancer patients http://t.co/dtouZ9yHtU 
Li et al. JCEM http://t.co/PdcBaJq56u #bcsm #…",7.155776,http://twitter.com/HCAOncNurseNav/status/461681250571653120,http://twitter.com/hcaoncnursenav
05/01/14,http://twitter.com/maurerstats/status/461682188111450112,maurerstats,"RT @mtmdphd: Vitamin D may raise survival rates among cancer patients http://t.co/dtouZ9yHtU 
Li et al. JCEM http://t.co/PdcBaJq56u #bcsm #…",7.155776,http://twitter.com/MaurerStats/status/461682188111450112,http://twitter.com/maurerstats
05/02/14,http://twitter.com/mdandersonnews/status/462323199620161536,mdandersonnews,5 things you should know before a stem cell transplant: http://t.co/ehtuA9Wyvz #cancer #lcsm #lymsm #endcancer,13.194327,http://twitter.com/MDAndersonNews/status/462323199620161536,http://twitter.com/mdandersonnews
05/02/14,http://twitter.com/ashp714/status/462323438116696064,ashp714,RT @MDAndersonNews: 5 things you should know before a stem cell transplant: http://t.co/ehtuA9Wyvz #cancer #lcsm #lymsm #endcancer,7.332584,http://twitter.com/ashp714/status/462323438116696064,http://twitter.com/ashp714
05/02/14,http://twitter.com/abbyprestin/status/462325656584716289,abbyprestin,RT @MDAndersonNews: 5 things you should know before a stem cell transplant: http://t.co/ehtuA9Wyvz #cancer #lcsm #lymsm #endcancer,7.332584,http://twitter.com/AbbyPrestin/status/462325656584716289,http://twitter.com/abbyprestin
05/02/14,http://twitter.com/rduranciarrochi/status/462326355917832193,rduranciarrochi,RT @MDAndersonNews: 5 things you should know before a stem cell transplant: http://t.co/ehtuA9Wyvz #cancer #lcsm #lymsm #endcancer,7.332584,http://twitter.com/RDURANCIARROCHI/status/462326355917832193,http://twitter.com/rduranciarrochi
05/02/14,http://twitter.com/cesargimenezg/status/462335154409574401,cesargimenezg,RT @MDAndersonNews: 5 things you should know before a stem cell transplant: http://t.co/ehtuA9Wyvz #cancer #lcsm #lymsm #endcancer,7.332584,http://twitter.com/cesargimenezg/status/462335154409574401,http://twitter.com/cesargimenezg
05/02/14,http://twitter.com/smerv/status/462351355110105089,smerv,RT @MDAndersonNews: 5 things you should know before a stem cell transplant: http://t.co/ehtuA9Wyvz #cancer #lcsm #lymsm #endcancer,10.500937,http://twitter.com/smerv/status/462351355110105089,http://twitter.com/smerv
05/02/14,http://twitter.com/myelomaweb/status/462363240391909376,myelomaweb,RT @MDAndersonNews: 5 things you should know before a stem cell transplant: http://t.co/ehtuA9Wyvz #cancer #lcsm #lymsm #endcancer,7.332584,http://twitter.com/myelomaweb/status/462363240391909376,http://twitter.com/myelomaweb
05/02/14,http://twitter.com/chrismcinturffc/status/462367308753960960,chrismcinturffc,RT @MDAndersonNews: 5 things you should know before a stem cell transplant: http://t.co/ehtuA9Wyvz #cancer #lcsm #lymsm #endcancer,7.332584,http://twitter.com/ChrisMcinturffc/status/462367308753960960,http://twitter.com/chrismcinturffc
05/03/14,http://twitter.com/scarlett_0hara/status/462422427453370368,scarlett_0hara,"RT @mtmdphd: Vitamin D may raise survival rates among cancer patients http://t.co/dtouZ9yHtU 
Li et al. JCEM http://t.co/PdcBaJq56u #bcsm #…",10.675218,http://twitter.com/scarlett_0hara/status/462422427453370368,http://twitter.com/scarlett_0hara
05/03/14,http://twitter.com/mlas/status/462424933369266177,mlas,"RT @mtmdphd: Vitamin D may raise survival rates among cancer patients http://t.co/dtouZ9yHtU 
Li et al. JCEM http://t.co/PdcBaJq56u #bcsm #…",10.524151,http://twitter.com/MLAS/status/462424933369266177,http://twitter.com/mlas
05/05/14,http://twitter.com/mdandersonnews/status/463309282302513152,mdandersonnews,"“#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #endcancer",13.228208,http://twitter.com/MDAndersonNews/status/463309282302513152,http://twitter.com/mdandersonnews
05/05/14,http://twitter.com/eazeetrade/status/463310561787125761,eazeetrade,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.296101,http://twitter.com/Eazeetrade/status/463310561787125761,http://twitter.com/eazeetrade
05/05/14,http://twitter.com/llsinri/status/463310847218319360,llsinri,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.296101,http://twitter.com/LLSinRI/status/463310847218319360,http://twitter.com/llsinri
05/05/14,http://twitter.com/msrima_/status/463311467291627520,msrima_,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.296101,http://twitter.com/MsRima_/status/463311467291627520,http://twitter.com/msrima_
05/05/14,http://twitter.com/jnci_now/status/463311887258906624,jnci_now,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.296101,http://twitter.com/JNCI_Now/status/463311887258906624,http://twitter.com/jnci_now
05/05/14,http://twitter.com/psukepp/status/463311983412920322,psukepp,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",10.496178,http://twitter.com/psukepp/status/463311983412920322,http://twitter.com/psukepp
05/05/14,http://twitter.com/mybabyleo11/status/463318641014870016,mybabyleo11,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.296101,http://twitter.com/mybabyleo11/status/463318641014870016,http://twitter.com/mybabyleo11
05/05/14,http://twitter.com/nocancersa/status/463324702707314689,nocancersa,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.296101,http://twitter.com/NoCancerSA/status/463324702707314689,http://twitter.com/nocancersa
05/05/14,http://twitter.com/twittachicca/status/463421503493926913,twittachicca,"RT @mtmdphd: Vitamin D may raise survival rates among cancer patients http://t.co/dtouZ9yHtU 
Li et al. JCEM http://t.co/PdcBaJq56u #bcsm #…",7.066798,http://twitter.com/TwittaChicca/status/463421503493926913,http://twitter.com/twittachicca
05/05/14,http://twitter.com/drmiguelperales/status/463423733261037569,drmiguelperales,#JCO ed by Paul Hamlin @sloan_kettering Evolving Treatment Paradigms for Primary Mediastinal DLBCL #lymsm @ASCO http://t.co/DlBqcfTzyt,9.026904,http://twitter.com/DrMiguelPerales/status/463423733261037569,http://twitter.com/drmiguelperales
05/05/14,http://twitter.com/drmiguelperales/status/463424333663064064,drmiguelperales,PET Predicts Survival After Chemoimmunotherapy for Primary Mediastinal DLBCL: IELSG-26 Study #JCO #lymsm @ASCO http://t.co/lKL90xYJgI,8.174163,http://twitter.com/DrMiguelPerales/status/463424333663064064,http://twitter.com/drmiguelperales
05/05/14,http://twitter.com/drzafergokgoz/status/463425106912358400,drzafergokgoz,RT @DrMiguelPerales: PET Predicts Survival After Chemoimmunotherapy for Primary Mediastinal DLBCL: IELSG-26 Study #JCO #lymsm @ASCO http://…,6.6331654,http://twitter.com/drzafergokgoz/status/463425106912358400,http://twitter.com/drzafergokgoz
05/05/14,http://twitter.com/drmiguelperales/status/463426961453248514,drmiguelperales,Patients with HL w PET+ dz post chemo &amp; poor tumor shrinkage at high risk of progression/relapse #lymsm #JCO @ASCO http://t.co/tj0S5YfzH3,11.721221,http://twitter.com/DrMiguelPerales/status/463426961453248514,http://twitter.com/drmiguelperales
05/05/14,http://twitter.com/asco/status/463430724230860800,asco,RT @DrMiguelPerales: Patients with HL w PET+ dz post chemo &amp; poor tumor shrinkage at high risk of progression/relapse #lymsm #JCO @ASCO htt…,10.15015,http://twitter.com/ASCO/status/463430724230860800,http://twitter.com/asco
05/05/14,http://twitter.com/last_ocram/status/463432326966677504,last_ocram,RT @DrMiguelPerales: Patients with HL w PET+ dz post chemo &amp; poor tumor shrinkage at high risk of progression/relapse #lymsm #JCO @ASCO htt…,6.811482,http://twitter.com/last_ocram/status/463432326966677504,http://twitter.com/last_ocram
05/05/14,http://twitter.com/natedahlpharmd/status/463438652043825152,natedahlpharmd,RT @DrMiguelPerales: #JCO ed by Paul Hamlin @sloan_kettering Evolving Treatment Paradigms for Primary Mediastinal DLBCL #lymsm @ASCO http:/…,6.8450584,http://twitter.com/NateDahlPharmD/status/463438652043825152,http://twitter.com/natedahlpharmd
05/05/14,http://twitter.com/aloeone_mark/status/463449281702424576,aloeone_mark,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.296101,http://twitter.com/Aloeone_Mark/status/463449281702424576,http://twitter.com/aloeone_mark
05/05/14,http://twitter.com/mskhemonctrials/status/463456106216710144,mskhemonctrials,RT @DrMiguelPerales: #JCO ed by Paul Hamlin @sloan_kettering Evolving Treatment Paradigms for Primary Mediastinal DLBCL #lymsm @ASCO http:/…,6.8450584,http://twitter.com/MSKHemOncTrials/status/463456106216710144,http://twitter.com/mskhemonctrials
05/06/14,http://twitter.com/transplant_doc/status/463522101429678080,transplant_doc,RT @DrMiguelPerales: PET Predicts Survival After Chemoimmunotherapy for Primary Mediastinal DLBCL: IELSG-26 Study #JCO #lymsm @ASCO http://…,6.6331654,http://twitter.com/Transplant_Doc/status/463522101429678080,http://twitter.com/transplant_doc
05/09/14,http://twitter.com/drmiguelperales/status/464586013235773440,drmiguelperales,Heading to Chicago tomorrow for @ALLIANCE_org meeting. Planning future studies in BMT #bmtsm #leusm #lymsm #mmsm,8.90883,http://twitter.com/DrMiguelPerales/status/464586013235773440,http://twitter.com/drmiguelperales
05/09/14,http://twitter.com/natedahlpharmd/status/464604528109948928,natedahlpharmd,RT @DrMiguelPerales: Heading to Chicago tomorrow for @ALLIANCE_org meeting. Planning future studies in BMT #bmtsm #leusm #lymsm #mmsm,7.0248356,http://twitter.com/NateDahlPharmD/status/464604528109948928,http://twitter.com/natedahlpharmd
05/09/14,http://twitter.com/alliance_org/status/464609850031632384,alliance_org,RT @DrMiguelPerales: Heading to Chicago tomorrow for @ALLIANCE_org meeting. Planning future studies in BMT #bmtsm #leusm #lymsm #mmsm,7.0248356,http://twitter.com/ALLIANCE_org/status/464609850031632384,http://twitter.com/alliance_org
05/11/14,http://twitter.com/mdandersonnews/status/465613162008428544,mdandersonnews,How a young cancer survivor is helping sick kids stay connected during treatment: http://t.co/W47WyZkgNf #endcancer #lymsm @KeepKidsConnect,11.960354,http://twitter.com/MDAndersonNews/status/465613162008428544,http://twitter.com/mdandersonnews
05/11/14,http://twitter.com/ihbercha/status/465613331303112704,ihbercha,RT @MDAndersonNews: How a young cancer survivor is helping sick kids stay connected during treatment: http://t.co/W47WyZkgNf #endcancer #ly…,7.315322,http://twitter.com/Ihbercha/status/465613331303112704,http://twitter.com/ihbercha
05/12/14,http://twitter.com/asbmt/status/465900055719731200,asbmt,June issue of #BBMT is now available online: http://t.co/SXHwknscNC #bmtsm #mmsm #lymsm #leusm #GVHD #cordblood http://t.co/uq0eTWmY6O,8.40212,http://twitter.com/ASBMT/status/465900055719731200,http://twitter.com/asbmt
05/12/14,http://twitter.com/lemaistrefred/status/465902140918366208,lemaistrefred,RT @ASBMT: June issue of #BBMT is now available online: http://t.co/SXHwknscNC #bmtsm #mmsm #lymsm #leusm #GVHD #cordblood http://t.co/uq0e…,6.877415,http://twitter.com/LemaistreFred/status/465902140918366208,http://twitter.com/lemaistrefred
05/12/14,http://twitter.com/amercancerfund/status/465904456102858752,amercancerfund,RT @MDAndersonNews: How a young cancer survivor is helping sick kids stay connected during treatment: http://t.co/W47WyZkgNf #endcancer #ly…,7.315322,http://twitter.com/AmerCancerFund/status/465904456102858752,http://twitter.com/amercancerfund
05/12/14,http://twitter.com/drmiguelperales/status/465907296556834818,drmiguelperales,RT @ASBMT: June issue of #BBMT is now available online: http://t.co/SXHwknscNC #bmtsm #mmsm #lymsm #leusm #GVHD #cordblood http://t.co/uq0e…,6.877415,http://twitter.com/DrMiguelPerales/status/465907296556834818,http://twitter.com/drmiguelperales
05/12/14,http://twitter.com/maurerstats/status/465959595471425536,maurerstats,"Clinical trial of VitD replacement in #lymphoma open at Mayo Clinic.  Open to DLBCL, PTCL, CLL.  #lymsm  http://t.co/t3zQugqDKF",7.2911186,http://twitter.com/MaurerStats/status/465959595471425536,http://twitter.com/maurerstats
05/13/14,http://twitter.com/drmiguelperales/status/466050903737249795,drmiguelperales,Subcut vs. IV Rituximab As Maintenance Treatment for Follicular Lymphoma: Two-Stage Phase IB Study #lymsm #JCO @ASCO http://t.co/OyMrEEGe8S,11.566893,http://twitter.com/DrMiguelPerales/status/466050903737249795,http://twitter.com/drmiguelperales
05/13/14,http://twitter.com/fischmd/status/466051186299510784,fischmd,RT @DrMiguelPerales: Subcut vs. IV Rituximab As Maintenance Treatment for Follicular Lymphoma: Two-Stage Phase IB Study #lymsm #JCO @ASCO h…,9.944811,http://twitter.com/fischmd/status/466051186299510784,http://twitter.com/fischmd
05/13/14,http://twitter.com/lilo_abernathy/status/466052998742175744,lilo_abernathy,RT @DrMiguelPerales: Subcut vs. IV Rituximab As Maintenance Treatment for Follicular Lymphoma: Two-Stage Phase IB Study #lymsm #JCO @ASCO h…,6.755338,http://twitter.com/Lilo_Abernathy/status/466052998742175744,http://twitter.com/lilo_abernathy
05/13/14,http://twitter.com/curepanel/status/466057970074132480,curepanel,RT @DrMiguelPerales: Subcut vs. IV Rituximab As Maintenance Treatment for Follicular Lymphoma: Two-Stage Phase IB Study #lymsm #JCO @ASCO h…,6.755338,http://twitter.com/CurePanel/status/466057970074132480,http://twitter.com/curepanel
05/13/14,http://twitter.com/subatomicdoc/status/466158610276311040,subatomicdoc,"Tumor Lysis Syndrome: Making Headway toward Better Prevention, Treatment http://t.co/XKclvbNvwA &gt;@OncologyTimes #leusm #lymsm",10.529155,http://twitter.com/subatomicdoc/status/466158610276311040,http://twitter.com/subatomicdoc
05/13/14,http://twitter.com/dawnka/status/466239118528086016,dawnka,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",10.5166445,http://twitter.com/DawnKA/status/466239118528086016,http://twitter.com/dawnka
05/14/14,http://twitter.com/mknoll_md/status/466549387968380928,mknoll_md,RT @DrMiguelPerales: Heading to Chicago tomorrow for @ALLIANCE_org meeting. Planning future studies in BMT #bmtsm #leusm #lymsm #mmsm,7.0248356,http://twitter.com/MKnoll_MD/status/466549387968380928,http://twitter.com/mknoll_md
05/14/14,http://twitter.com/asbmt/status/466555059904323585,asbmt,New in #BBMT: Impact of CMV Replication &amp; Serostatus on outcome of Pts w BCell #Lymphoma after Allo-HCT http://t.co/kkDq8pDyz4 #bmtsm #lymsm,8.758548,http://twitter.com/ASBMT/status/466555059904323585,http://twitter.com/asbmt
05/14/14,http://twitter.com/timfenske/status/466562381582467073,timfenske,RT @ASBMT: New in #BBMT: Impact of CMV Replication &amp; Serostatus on outcome of Pts w BCell #Lymphoma after Allo-HCT http://t.co/kkDq8pDyz4 #…,6.5488954,http://twitter.com/timfenske/status/466562381582467073,http://twitter.com/timfenske
05/14/14,http://twitter.com/beachlady17/status/466567222480367617,beachlady17,RT @ASBMT: New in #BBMT: Impact of CMV Replication &amp; Serostatus on outcome of Pts w BCell #Lymphoma after Allo-HCT http://t.co/kkDq8pDyz4 #…,6.5488954,http://twitter.com/BeachLady17/status/466567222480367617,http://twitter.com/beachlady17
05/14/14,http://twitter.com/asbmt/status/466625274251988992,asbmt,New #BBMT: Pre-HCT PET Lacks Prognostic Value in Chemosensitive BCell NHL Pts Undergoing NMA Allo-HCT #lymsm #bmtsm http://t.co/3MswKjWkJD,8.892958,http://twitter.com/ASBMT/status/466625274251988992,http://twitter.com/asbmt
05/14/14,http://twitter.com/gmcrotty/status/466626379942211584,gmcrotty,RT @ASBMT: New #BBMT: Pre-HCT PET Lacks Prognostic Value in Chemosensitive BCell NHL Pts Undergoing NMA Allo-HCT #lymsm #bmtsm http://t.co/…,6.338458,http://twitter.com/gmcrotty/status/466626379942211584,http://twitter.com/gmcrotty
05/14/14,http://twitter.com/pallioncmd423/status/466629698911367168,pallioncmd423,RT @ASBMT: New #BBMT: Pre-HCT PET Lacks Prognostic Value in Chemosensitive BCell NHL Pts Undergoing NMA Allo-HCT #lymsm #bmtsm http://t.co/…,6.338458,http://twitter.com/pallioncmd423/status/466629698911367168,http://twitter.com/pallioncmd423
05/14/14,http://twitter.com/citohans/status/466631796067954690,citohans,RT @ASBMT: New #BBMT: Pre-HCT PET Lacks Prognostic Value in Chemosensitive BCell NHL Pts Undergoing NMA Allo-HCT #lymsm #bmtsm http://t.co/…,6.338458,http://twitter.com/citohans/status/466631796067954690,http://twitter.com/citohans
05/15/14,http://twitter.com/mtmdphd/status/466775678218928129,mtmdphd,@timfenske typo? Similar outcomes and lower toxicity (improved safety profile) #lymsm,10.533267,http://twitter.com/mtmdphd/status/466775678218928129,http://twitter.com/mtmdphd
05/15/14,http://twitter.com/mtmdphd/status/466778508195528704,mtmdphd,Restaging BMBx may not be necessary at end of therapy in  DLBCL http://t.co/fRn6OTyDMW Jackson et al. #ASCO14 Ab 8541 MT @timfenske #lymsm,11.334939,http://twitter.com/mtmdphd/status/466778508195528704,http://twitter.com/mtmdphd
05/15/14,http://twitter.com/drhedrick/status/466779437027966976,drhedrick,RT @mtmdphd: Restaging BMBx may not be necessary at end of therapy in  DLBCL http://t.co/fRn6OTyDMW Jackson et al. #ASCO14 Ab 8541 MT @timf…,6.810025,http://twitter.com/DrHedrick/status/466779437027966976,http://twitter.com/drhedrick
05/15/14,http://twitter.com/mtmdphd/status/466922222909919233,mtmdphd,"Vitamin D may raise survival rates among cancer patients http://t.co/PoTG54HIgI 
Li et al. JCEM http://t.co/sF9XBIzOD6 #bcsm #crcsm #lymsm",11.201904,http://twitter.com/mtmdphd/status/466922222909919233,http://twitter.com/mtmdphd
05/15/14,http://twitter.com/hcaoncnursenav/status/466929122682601472,hcaoncnursenav,"RT @mtmdphd: Vitamin D may raise survival rates among cancer patients http://t.co/PoTG54HIgI 
Li et al. JCEM http://t.co/sF9XBIzOD6 #bcsm #…",7.148245,http://twitter.com/HCAOncNurseNav/status/466929122682601472,http://twitter.com/hcaoncnursenav
05/15/14,http://twitter.com/fischmd/status/466967292598030336,fischmd,RT @mtmdphd: Restaging BMBx may not be necessary at end of therapy in  DLBCL http://t.co/fRn6OTyDMW Jackson et al. #ASCO14 Ab 8541 MT @timf…,9.999498,http://twitter.com/fischmd/status/466967292598030336,http://twitter.com/fischmd
05/15/14,http://twitter.com/sequentainc/status/466971647610986497,sequentainc,Still sorting thru #ASCO14 abstracts? Sequenta &amp; collaborators will present #immunotherapy &amp; #bloodcancer data http://t.co/7GiKDUUtCs #lymsm,6.678978,http://twitter.com/SequentaInc/status/466971647610986497,http://twitter.com/sequentainc
05/15/14,http://twitter.com/drmiguelperales/status/466993591987212288,drmiguelperales,ORR 41% in relapsed T-cell lymphomas w brentuximab by S. Horwitz @sloan_kettering http://t.co/mdCnmnlJB3 #lymsm #BloodJournal,7.546524,http://twitter.com/DrMiguelPerales/status/466993591987212288,http://twitter.com/drmiguelperales
05/15/14,http://twitter.com/mtmdphd/status/467016637863186432,mtmdphd,WAHO Educational Symposium May 21 6pm @InterConMKE w/ Dr. Thomas Habermann of @MayoClinic http://t.co/OcMkIwuo4R  #lymsm #leusm #mmsm,11.239193,http://twitter.com/mtmdphd/status/467016637863186432,http://twitter.com/mtmdphd
05/15/14,http://twitter.com/interconmke/status/467032536682872833,interconmke,RT @mtmdphd: WAHO Educational Symposium May 21 6pm @InterConMKE w/ Dr. Thomas Habermann of @MayoClinic http://t.co/OcMkIwuo4R  #lymsm #leus…,10.117626,http://twitter.com/InterConMKE/status/467032536682872833,http://twitter.com/interconmke
05/15/14,http://twitter.com/maurerstats/status/467050424604717056,maurerstats,RT @MayoClinicLymph Open #study: Adults with relapsed/ refractory #DLBCL http://t.co/72bqQhIZOv #clinicaltrials #lymphoma #lymsm,7.224738,http://twitter.com/MaurerStats/status/467050424604717056,http://twitter.com/maurerstats
05/16/14,http://twitter.com/arrangoiz14/status/467123525053317120,arrangoiz14,RT @DrMiguelPerales: Patients with HL w PET+ dz post chemo &amp; poor tumor shrinkage at high risk of progression/relapse #lymsm #JCO @ASCO htt…,6.706342,http://twitter.com/arrangoiz14/status/467123525053317120,http://twitter.com/arrangoiz14
05/16/14,http://twitter.com/mtmdphd/status/467288396906242048,mtmdphd,WAHO Educational Symposium May 21 6pm @InterConMKE w/ Dr. Thomas Habermann of @MayoClinic http://t.co/OcMkIwuo4R #lymsm #leusm #mmsm,11.262027,http://twitter.com/mtmdphd/status/467288396906242048,http://twitter.com/mtmdphd
05/16/14,http://twitter.com/maurerstats/status/467299493033955328,maurerstats,RT @mtmdphd: WAHO Educational Symposium May 21 6pm @InterConMKE w/ Dr. Thomas Habermann of @MayoClinic http://t.co/OcMkIwuo4R #lymsm #leusm…,6.8240585,http://twitter.com/MaurerStats/status/467299493033955328,http://twitter.com/maurerstats
05/16/14,http://twitter.com/crystaleitnier/status/467299624337018880,crystaleitnier,RT @mtmdphd: WAHO Educational Symposium May 21 6pm @InterConMKE w/ Dr. Thomas Habermann of @MayoClinic http://t.co/OcMkIwuo4R #lymsm #leusm…,6.8240585,http://twitter.com/CrystalEitnier/status/467299624337018880,http://twitter.com/crystaleitnier
05/16/14,http://twitter.com/mtmdphd/status/467351347277611008,mtmdphd,WAHO Educational Symposium May 21 6pm @InterConMKE w/ Dr. Thomas Habermann of @MayoClinic http://t.co/E8V8fgdLjk  #lymsm #leusm #mmsm,10.151178,http://twitter.com/mtmdphd/status/467351347277611008,http://twitter.com/mtmdphd
05/18/14,http://twitter.com/mtmdphd/status/468106291525992448,mtmdphd,WAHO Educational Symposium May 21 6pm @InterConMKE w/ Dr. Thomas Habermann of @MayoClinic http://t.co/UILiAfe5Ln  #lymsm #leusm #mmsm,10.12273,http://twitter.com/mtmdphd/status/468106291525992448,http://twitter.com/mtmdphd
05/19/14,http://twitter.com/fischmd/status/468368104746397696,fischmd,RT @ASCOPost: NCCN Clinical Practice Guidelines in #Oncology: 2014 Updates http://t.co/Vj2QMjPuez #hpm #bcsm #lymsm,11.809981,http://twitter.com/fischmd/status/468368104746397696,http://twitter.com/fischmd
05/19/14,http://twitter.com/meehan_jeff/status/468368416240574464,meehan_jeff,RT @fischmd: RT @ASCOPost: NCCN Clinical Practice Guidelines in #Oncology: 2014 Updates http://t.co/Vj2QMjPuez #hpm #bcsm #lymsm,7.0729194,http://twitter.com/meehan_jeff/status/468368416240574464,http://twitter.com/meehan_jeff
05/19/14,http://twitter.com/maurerstats/status/468381431413346304,maurerstats,"RT @ASCOPost: Andrew D. Zelenetz, MD, PhD, on Treating the Elderly #Lymphoma Patient With Elevated Bilirubin http://t.co/T8OM10GzBN #lymsm",7.053157,http://twitter.com/MaurerStats/status/468381431413346304,http://twitter.com/maurerstats
05/19/14,http://twitter.com/dylanaarsenault/status/468382397998723073,dylanaarsenault,RT @fischmd: RT @ASCOPost: NCCN Clinical Practice Guidelines in #Oncology: 2014 Updates http://t.co/Vj2QMjPuez #hpm #bcsm #lymsm,7.0729194,http://twitter.com/DylanaArsenault/status/468382397998723073,http://twitter.com/dylanaarsenault
05/19/14,http://twitter.com/davidgrahammd/status/468411093107212288,davidgrahammd,"In advance of my #ASCO14 talk, an Aussie lymphoma trials app that has had serious impact http://t.co/i8HcC4rBG8 #lymsm",8.322221,http://twitter.com/davidgrahammd/status/468411093107212288,http://twitter.com/davidgrahammd
05/19/14,http://twitter.com/elaineleung/status/468418155476701184,elaineleung,Nice one for rarer diseases! Clintrial Refer- a Mobile App To Connect patient v @davidgrahammd #ASCO14 http://t.co/MkhIr7ZyGA #lymsm,6.935809,http://twitter.com/elaineleung/status/468418155476701184,http://twitter.com/elaineleung
05/19/14,http://twitter.com/mdroeland/status/468434396714778624,mdroeland,RT @fischmd: RT @ASCOPost: NCCN Clinical Practice Guidelines in #Oncology: 2014 Updates http://t.co/Vj2QMjPuez #hpm #bcsm #lymsm,7.0729194,http://twitter.com/MDRoeland/status/468434396714778624,http://twitter.com/mdroeland
05/19/14,http://twitter.com/mdanderson_poe/status/468439714383417345,mdanderson_poe,RT @fischmd @ASCOPost: NCCN Clinical Practice Guidelines in #Oncology: 2014 Updates http://t.co/lpyRGDJFpG #hpm #bcsm #lymsm,7.0698915,http://twitter.com/MDAnderson_POE/status/468439714383417345,http://twitter.com/mdanderson_poe
05/20/14,http://twitter.com/drmiguelperales/status/468703782105534464,drmiguelperales,"Good review in BMT: Managing Hodgkin lymphoma relapsing after autologous HCT Kharfan-Dabaja, M A et. al #bmtsm #lymsm http://t.co/dFjRsTHWOZ",9.145494,http://twitter.com/DrMiguelPerales/status/468703782105534464,http://twitter.com/drmiguelperales
05/20/14,http://twitter.com/onyxpharm/status/468831009048629248,onyxpharm,"We’ll be following #cancer researcher Dr. Thompson, @mtmdphd, for hem/onc updates during #ASCO14. #lymsm #mmsm  #lymphoma #myeloma",6.960866,http://twitter.com/OnyxPharm/status/468831009048629248,http://twitter.com/onyxpharm
05/20/14,http://twitter.com/drmarkham/status/468851279750791168,drmarkham,Primary CNS Lymphoma: Biggest Challenge Seen as Disease Control (via @onclogytimes) http://t.co/nfTYZCc0Yf #lymsm,10.720977,http://twitter.com/DrMarkham/status/468851279750791168,http://twitter.com/drmarkham
05/20/14,http://twitter.com/transplant_doc/status/468863755032743937,transplant_doc,"RT @DrMiguelPerales: Good review in BMT: Managing Hodgkin lymphoma relapsing after autologous HCT Kharfan-Dabaja, M A et. al #bmtsm #lymsm …",6.5654187,http://twitter.com/Transplant_Doc/status/468863755032743937,http://twitter.com/transplant_doc
05/21/14,http://twitter.com/doctorpemm/status/468940721131896834,doctorpemm,"RT @DrMiguelPerales: Good review in BMT: Managing Hodgkin lymphoma relapsing after autologous HCT Kharfan-Dabaja, M A et. al #bmtsm #lymsm …",6.5654187,http://twitter.com/doctorpemm/status/468940721131896834,http://twitter.com/doctorpemm
05/21/14,http://twitter.com/9872002685/status/468951499159384065,9872002685,"RT @DrMiguelPerales: Good review in BMT: Managing Hodgkin lymphoma relapsing after autologous HCT Kharfan-Dabaja, M A et. al #bmtsm #lymsm …",6.5654187,http://twitter.com/9872002685/status/468951499159384065,http://twitter.com/9872002685
05/21/14,http://twitter.com/drmiguelperales/status/468954873614974976,drmiguelperales,Ofatumumab Not Superior to Rituximab in DLBCL Study http://t.co/qFzXgKF4Du via @TargetedOnc #lymsm,7.2369556,http://twitter.com/DrMiguelPerales/status/468954873614974976,http://twitter.com/drmiguelperales
05/21/14,http://twitter.com/mtmdphd/status/469101390422605824,mtmdphd,WAHO Educational Symposium May 21 6pm @InterConMKE w/ Dr. Thomas Habermann of @MayoClinic http://t.co/o8vpUgg8To #lymsm #leusm #mmsm,10.103747,http://twitter.com/mtmdphd/status/469101390422605824,http://twitter.com/mtmdphd
05/22/14,http://twitter.com/andreaskleinmd/status/469282272760594432,andreaskleinmd,Thanks for another great year of lymphoma cases and camaraderie! @lymphoma  #lymsm,7.687355,http://twitter.com/AndreasKleinMD/status/469282272760594432,http://twitter.com/andreaskleinmd
05/22/14,http://twitter.com/mtmdphd/status/469291039107604481,mtmdphd,Habermann rocking an #ASH13 review for WAHO. Many mentions of @GregNowakowski @MaurerStats @MayoMyeloma #mmsm #lymsm,10.025548,http://twitter.com/mtmdphd/status/469291039107604481,http://twitter.com/mtmdphd
05/22/14,http://twitter.com/drmiguelperales/status/469416417931300864,drmiguelperales,Video: Phase I Clinical Trial of Anti-PD-1 in Hematologic Malignancy http://t.co/ly318z7uWx #lymsm #leusm #mmsm,6.9011393,http://twitter.com/DrMiguelPerales/status/469416417931300864,http://twitter.com/drmiguelperales
05/22/14,http://twitter.com/maurerstats/status/469491395485392896,maurerstats,MT @Lymphomation: #ASCO14  Abstracts:  #Lymphoma and Plasma Cell Disorders : Lymphoma http://t.co/k1g5BAKYF3 #lymsm,7.1879807,http://twitter.com/MaurerStats/status/469491395485392896,http://twitter.com/maurerstats
05/22/14,http://twitter.com/mtmdphd/status/469605166573170688,mtmdphd,FDA’s Orphan Drug Status to Selinexor—Now for DLBCL - @OncologyTimes http://t.co/0nLFhaDCI1 #lymsm,10.06709,http://twitter.com/mtmdphd/status/469605166573170688,http://twitter.com/mtmdphd
05/22/14,http://twitter.com/hematologo/status/469607230506291200,hematologo,"“@mtmdphd: FDA’s Orphan Drug Status to Selinexor—Now for DLBCL - @OncologyTimes http://t.co/O5yunlEbx5 #lymsm” // another ""bullet"" for DLBCL",6.733162,http://twitter.com/hematologo/status/469607230506291200,http://twitter.com/hematologo
05/22/14,http://twitter.com/mtmdphd/status/469608717953282048,mtmdphd,R2-CHOP21 Highly Active in Elderly Untreated Diffuse Large B-Cell Lymphoma Pts - @ASCOPost http://t.co/CPzNZZd9kp #lymsm,10.786974,http://twitter.com/mtmdphd/status/469608717953282048,http://twitter.com/mtmdphd
05/22/14,http://twitter.com/dsobek/status/469611515465568256,dsobek,RT @mtmdphd: R2-CHOP21 Highly Active in Elderly Untreated Diffuse Large B-Cell Lymphoma Pts - @ASCOPost http://t.co/CPzNZZd9kp #lymsm,9.867698,http://twitter.com/dsobek/status/469611515465568256,http://twitter.com/dsobek
05/23/14,http://twitter.com/mdandersonnews/status/469651573426384896,mdandersonnews,"“#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #endcancer",13.206581,http://twitter.com/MDAndersonNews/status/469651573426384896,http://twitter.com/mdandersonnews
05/23/14,http://twitter.com/baronianconsult/status/469651926725189633,baronianconsult,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/BaronianConsult/status/469651926725189633,http://twitter.com/baronianconsult
05/23/14,http://twitter.com/julieolagbegi/status/469653190137630720,julieolagbegi,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/JulieOlagbegi/status/469653190137630720,http://twitter.com/julieolagbegi
05/23/14,http://twitter.com/jteh_pench02/status/469653253731266561,jteh_pench02,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/jteh_pench02/status/469653253731266561,http://twitter.com/jteh_pench02
05/23/14,http://twitter.com/dawnka/status/469657331257860097,dawnka,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",10.53774,http://twitter.com/DawnKA/status/469657331257860097,http://twitter.com/dawnka
05/23/14,http://twitter.com/jailan82/status/469669194163060736,jailan82,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/jailan82/status/469669194163060736,http://twitter.com/jailan82
05/23/14,http://twitter.com/tealbutterflie/status/469674058582605824,tealbutterflie,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/TealButterflie/status/469674058582605824,http://twitter.com/tealbutterflie
05/23/14,http://twitter.com/caroline_vos66/status/469716126638026752,caroline_vos66,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/caroline_vos66/status/469716126638026752,http://twitter.com/caroline_vos66
05/23/14,http://twitter.com/arieshorse/status/469747492188196865,arieshorse,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/arieshorse/status/469747492188196865,http://twitter.com/arieshorse
05/23/14,http://twitter.com/aloeone_mark/status/469770348804988929,aloeone_mark,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/Aloeone_Mark/status/469770348804988929,http://twitter.com/aloeone_mark
05/23/14,http://twitter.com/sharkaye/status/469790352069898240,sharkaye,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/sharkaye/status/469790352069898240,http://twitter.com/sharkaye
05/23/14,http://twitter.com/ldgreen66/status/469878230690713600,ldgreen66,"RT @MDAndersonNews: “#Cancer is a life-changing experience, but it was not the end of the world.” http://t.co/HBwPb6f5uX #lymphoma #lymsm #…",7.317197,http://twitter.com/LDGreen66/status/469878230690713600,http://twitter.com/ldgreen66
05/23/14,http://twitter.com/drmarkham/status/469938399949119490,drmarkham,From @asco &amp; #ASCO14 Education Book: Surveillance Imaging for Lymphoma: Pros and Cons http://t.co/lsCsXLu6S1 #lymsm,11.03453,http://twitter.com/DrMarkham/status/469938399949119490,http://twitter.com/drmarkham
05/27/14,http://twitter.com/sequentainc/status/471275107307241472,sequentainc,Excited #ASCO14 is almost here! Sequenta (booth 18152) presenting data related to #lymphoma &amp; #immunotherapy http://t.co/L7FbRV6dyD #lymsm,6.9094586,http://twitter.com/SequentaInc/status/471275107307241472,http://twitter.com/sequentainc
05/27/14,http://twitter.com/maurerstats/status/471291809638125568,maurerstats,RT @DrMarkham From @asco &amp; #ASCO14 Education Book: Surveillance Imaging for #Lymphoma: Pros and Cons http://t.co/PKbJepmjya  #lymsm,6.952963,http://twitter.com/MaurerStats/status/471291809638125568,http://twitter.com/maurerstats
05/27/14,http://twitter.com/mtmdphd/status/471299897074139136,mtmdphd,Appropriate Management of Molecular Subtypes of DLBCL - Dunleavy &amp; Wilson @CancerNetwrk http://t.co/7u73ZCGRCD #lymsm,11.270038,http://twitter.com/mtmdphd/status/471299897074139136,http://twitter.com/mtmdphd
05/27/14,http://twitter.com/drzafergokgoz/status/471307415858999296,drzafergokgoz,RT @mtmdphd: Appropriate Management of Molecular Subtypes of DLBCL - Dunleavy &amp; Wilson @CancerNetwrk http://t.co/7u73ZCGRCD #lymsm,6.866395,http://twitter.com/drzafergokgoz/status/471307415858999296,http://twitter.com/drzafergokgoz
05/27/14,http://twitter.com/sequentainc/status/471320428959776769,sequentainc,3 days ‘til #ASCO14! We're following @mtmdphd &amp; @DrMarkham for #lymsm &amp; #mmsm news &amp; checkout @ASCO’s #hcsm guide http://t.co/eHeCGuW7Dq,7.4065742,http://twitter.com/SequentaInc/status/471320428959776769,http://twitter.com/sequentainc
05/27/14,http://twitter.com/maurerstats/status/471323190501707777,maurerstats,RT @mtmdphd: Appropriate Management of Molecular Subtypes of DLBCL - Dunleavy &amp; Wilson @CancerNetwrk http://t.co/7u73ZCGRCD #lymsm,6.866395,http://twitter.com/MaurerStats/status/471323190501707777,http://twitter.com/maurerstats
05/27/14,http://twitter.com/maurerstats/status/471361782309613568,maurerstats,Looking forward to following everything at #ASCO14 via @mtmdphd @DrMarkham @drdonsdizon on Twitter this year.  #lymsm #gynsm #lymphoma,7.856995,http://twitter.com/MaurerStats/status/471361782309613568,http://twitter.com/maurerstats
05/27/14,http://twitter.com/drdonsdizon/status/471362468611358720,drdonsdizon,“@MaurerStats: Looking 4ward to following #ASCO14 via  Twitter this year.  #lymsm #gynsm #lymphoma” TY 4 that! DSD @DrMarkham @mtmdphd MT,6.8818955,http://twitter.com/drdonsdizon/status/471362468611358720,http://twitter.com/drdonsdizon
05/28/14,http://twitter.com/maurerstats/status/471468171472285696,maurerstats,"RT @davidgrahammd: In advance of my #ASCO14 talk, an Aussie lymphoma trials app that has had serious impact http://t.co/i8HcC4rBG8 #lymsm",7.2732882,http://twitter.com/MaurerStats/status/471468171472285696,http://twitter.com/maurerstats
05/28/14,http://twitter.com/ash_hematology/status/471679566134927360,ash_hematology,"RT @davidgrahammd: In advance of my #ASCO14 talk, an Aussie lymphoma trials app that has had serious impact http://t.co/LsOgTR39cE #lymsm",7.3017097,http://twitter.com/ASH_hematology/status/471679566134927360,http://twitter.com/ash_hematology
05/28/14,http://twitter.com/sequentainc/status/471735430015377408,sequentainc,What #ASCO14 #bloodcancer data excites you? (http://t.co/1kQ0qxrSIU) #mmsm #lymsm,9.355211,http://twitter.com/SequentaInc/status/471735430015377408,http://twitter.com/sequentainc
05/28/14,http://twitter.com/onyxpharm/status/471760846322814977,onyxpharm,Looking forward to hearing new info on #myeloma at #ASCO14. We’ve come a long way but still work to be done in #oncology. #mmsm #lymsm,8.023823,http://twitter.com/OnyxPharm/status/471760846322814977,http://twitter.com/onyxpharm
05/29/14,http://twitter.com/mayocliniclymph/status/472075724270997504,mayocliniclymph,Every 4 minutes someone is diagnosed w/ a #bloodcancer! Learn more w/ #interactive timeline from @BeTheMatch: http://t.co/YNTdtRbWWQ #lymsm,7.537139,http://twitter.com/MayoClinicLymph/status/472075724270997504,http://twitter.com/mayocliniclymph
05/30/14,http://twitter.com/myelomateacher/status/472180350672982017,myelomateacher,RT @SequentaInc: What #ASCO14 #bloodcancer data excites you? (http://t.co/1kQ0qxrSIU) #mmsm #lymsm,7.1086836,http://twitter.com/MyelomaTeacher/status/472180350672982017,http://twitter.com/myelomateacher
05/30/14,http://twitter.com/drmiguelperales/status/472188964066299904,drmiguelperales,Ph I/II of romidepsin + lenalidomide in relrefr lymphoma &amp; myeloma http://t.co/KOiH8qHqva @sloan_kettering study @ #ASCO14 #mmsm #lymsm,7.6487384,http://twitter.com/DrMiguelPerales/status/472188964066299904,http://twitter.com/drmiguelperales
05/30/14,http://twitter.com/paulasbickley/status/472311775959203840,paulasbickley,RT @SequentaInc: What #ASCO14 #bloodcancer data excites you? (http://t.co/1kQ0qxrSIU) #mmsm #lymsm,7.1086836,http://twitter.com/PaulaSBickley/status/472311775959203840,http://twitter.com/paulasbickley
05/30/14,http://twitter.com/mtmdphd/status/472355567013732352,mtmdphd,Evaluation of Diffusion-Wt MRI for Pretherapeutic Assessment &amp; Staging of Lymphoma - Mayerhoefer et al. CCR http://t.co/2lTF6Se98i #lymsm,10.584994,http://twitter.com/mtmdphd/status/472355567013732352,http://twitter.com/mtmdphd
05/30/14,http://twitter.com/cd_fuller/status/472357679285817344,cd_fuller,RT @mtmdphd: Evaluation of Diffusion-Wt MRI for Pretherapeutic Assessment &amp; Staging of Lymphoma - Mayerhoefer et al. CCR http://t.co/2lTF6S…,6.596392,http://twitter.com/cd_fuller/status/472357679285817344,http://twitter.com/cd_fuller
05/30/14,http://twitter.com/drmarkham/status/472371304780541953,drmarkham,"If you're interested in #gyncsm or #lymsm (or anything else I find worth sharing) at #ASCO14, stay tuned over next few days!",12.408959,http://twitter.com/DrMarkham/status/472371304780541953,http://twitter.com/drmarkham
05/30/14,http://twitter.com/maurerstats/status/472371912270942208,maurerstats,"Looking forward to it! MT  @DrMarkham If you're interested in #gyncsm or #lymsm at #ASCO14, stay tuned over next few days!",7.9700804,http://twitter.com/MaurerStats/status/472371912270942208,http://twitter.com/maurerstats
05/30/14,http://twitter.com/drattai/status/472379021389344768,drattai,"RT @DrMarkham: If you're interested in #gyncsm or #lymsm (or anything else I find worth sharing) at #ASCO14, stay tuned over next few days!",10.402458,http://twitter.com/drattai/status/472379021389344768,http://twitter.com/drattai
05/30/14,http://twitter.com/asco/status/472379392023605248,asco,"RT @DrMarkham: If you're interested in #gyncsm or #lymsm (or anything else I find worth sharing) at #ASCO14, stay tuned over next few days!",10.490796,http://twitter.com/ASCO/status/472379392023605248,http://twitter.com/asco
05/30/14,http://twitter.com/myelomateacher/status/472381025881169920,myelomateacher,RT @DrMiguelPerales: Ph I/II of romidepsin + lenalidomide in relrefr lymphoma &amp; myeloma http://t.co/KOiH8qHqva @sloan_kettering study @ #AS…,6.6195183,http://twitter.com/MyelomaTeacher/status/472381025881169920,http://twitter.com/myelomateacher
05/30/14,http://twitter.com/medzineapp/status/472382561520721920,medzineapp,"RT @DrMarkham: If you're interested in #gyncsm or #lymsm (or anything else I find worth sharing) at #ASCO14, stay tuned over next few days!",7.152128,http://twitter.com/Medzineapp/status/472382561520721920,http://twitter.com/medzineapp
05/30/14,http://twitter.com/prime_oncology/status/472434452761939968,prime_oncology,"We've got some great #CME symposia coming up this weekend at #ASCO14 in #lcsm, #gucsm, and #lymsm 
http://t.co/8QS4128FtW 
#primeonc",8.347161,http://twitter.com/prIME_Oncology/status/472434452761939968,http://twitter.com/prime_oncology
05/30/14,http://twitter.com/kingsteub/status/472439164349448192,kingsteub,"RT @prIME_Oncology: We've got some great #CME symposia coming up this weekend at #ASCO14 in #lcsm, #gucsm, and #lymsm 
http://t.co/8QS4128F…",6.856244,http://twitter.com/Kingsteub/status/472439164349448192,http://twitter.com/kingsteub
05/30/14,http://twitter.com/mtmdphd/status/472441420230713344,mtmdphd,Listening to lung cancer biomarker / -omics sitting next to lymphoma expert @GregNowakowski &lt;- encouraging him to #lymsm tweet... &lt;taunt&gt;,10.160072,http://twitter.com/mtmdphd/status/472441420230713344,http://twitter.com/mtmdphd
05/30/14,http://twitter.com/mtmdphd/status/472443358506274816,mtmdphd,Open - #EAOnc Ph2 RCT Lenalidomide R-CHOP (R2CHOP) vs RCHOP in DLBCL - http://t.co/hEh8tTcQtd @GregNowakowski #lymsm,10.374347,http://twitter.com/mtmdphd/status/472443358506274816,http://twitter.com/mtmdphd
05/30/14,http://twitter.com/maurerstats/status/472445076027633664,maurerstats,RT @mtmdphd  #EAOnc Ph2 RCT Lenalidomide R-CHOP (R2CHOP) vs RCHOP in DLBCL - http://t.co/YEYThxoUwk … @GregNowakowski #lymsm,6.5560007,http://twitter.com/MaurerStats/status/472445076027633664,http://twitter.com/maurerstats
05/30/14,http://twitter.com/vincentrk/status/472449619729735680,vincentrk,RT @mtmdphd: Open - #EAOnc Ph2 RCT Lenalidomide R-CHOP (R2CHOP) vs RCHOP in DLBCL - http://t.co/hEh8tTcQtd @GregNowakowski #lymsm,6.405902,http://twitter.com/VincentRK/status/472449619729735680,http://twitter.com/vincentrk
05/30/14,http://twitter.com/mtmdphd/status/472451238911414272,mtmdphd,R2CHOP DLBCL data w/ @GregNowakowski Sat 5/31 - 2:03-2:15p E Arie Crown Theater #lymsm #ASCO14,9.924024,http://twitter.com/mtmdphd/status/472451238911414272,http://twitter.com/mtmdphd
05/30/14,http://twitter.com/rojasanne/status/472454915458342912,rojasanne,"RT @prIME_Oncology: We've got some great #CME symposia coming up this weekend at #ASCO14 in #lcsm, #gucsm, and #lymsm 
http://t.co/8QS4128F…",6.856244,http://twitter.com/rojasanne/status/472454915458342912,http://twitter.com/rojasanne
05/30/14,http://twitter.com/maurerstats/status/472456232754634752,maurerstats,MT @ALLIANCE_org #ASCO14 CALGB-50803: Phase2 trial of R+lenolidomide in pts w/ prev untreat FL http://t.co/dC07MKDD9I … #AllianceNCTN #lymsm,10.489434,http://twitter.com/MaurerStats/status/472456232754634752,http://twitter.com/maurerstats
05/30/14,http://twitter.com/drcbsteer/status/472474176977387521,drcbsteer,RT @DrMarkham: From @asco &amp; #ASCO14 Education Book: Surveillance Imaging for Lymphoma: Pros and Cons http://t.co/lsCsXLu6S1 #lymsm,7.027251,http://twitter.com/drcbsteer/status/472474176977387521,http://twitter.com/drcbsteer
05/30/14,http://twitter.com/drcbsteer/status/472477677371523072,drcbsteer,#ASCO14 #geriatriconcology #lymsm #CLL #myeloma Great to see a full room of people learning about haem malignancies in olde adults,6.9821124,http://twitter.com/drcbsteer/status/472477677371523072,http://twitter.com/drcbsteer
05/30/14,http://twitter.com/ash_hematology/status/472480238371610625,ash_hematology,RT @drcbsteer: #ASCO14 #geriatriconcology #lymsm #CLL #myeloma Great to see a full room of people learning about haem malignancies in...,11.453088,http://twitter.com/ASH_hematology/status/472480238371610625,http://twitter.com/ash_hematology
05/30/14,http://twitter.com/drcbsteer/status/472480670280073216,drcbsteer,RT @ASH_hematology: RT @drcbsteer: #ASCO14 #geriatriconcology #lymsm #CLL #myeloma Great to see a full room of people learning about haem m…,6.884983,http://twitter.com/drcbsteer/status/472480670280073216,http://twitter.com/drcbsteer
05/30/14,http://twitter.com/asco/status/472483730725298176,asco,RT @ASH_hematology: RT @drcbsteer: #ASCO14 #geriatriconcology #lymsm #CLL #myeloma Great to see a full room of people learning about haem m…,10.223651,http://twitter.com/ASCO/status/472483730725298176,http://twitter.com/asco
05/30/14,http://twitter.com/mtmdphd/status/472487432433065984,mtmdphd,MT @MayoClinicLymph: Dr. Carrie Thompson discusses study of CT in DLBCL http://t.co/qbv1MyY8ka #lymsm,10.558682,http://twitter.com/mtmdphd/status/472487432433065984,http://twitter.com/mtmdphd
05/30/14,http://twitter.com/drcbsteer/status/472492806968463360,drcbsteer,#asco14 ABT199 active in relapsed lymphoma including an encouraging RR in Mantle cell #lymsm,7.217414,http://twitter.com/drcbsteer/status/472492806968463360,http://twitter.com/drcbsteer
05/30/14,http://twitter.com/maurerstats/status/472499209073983488,maurerstats,MT @StefanoLuminari #ASCO14 #lymphoma poster highlight conclusions by dr Smith http://t.co/fjJG9yvy8J #lymsm,7.3000426,http://twitter.com/MaurerStats/status/472499209073983488,http://twitter.com/maurerstats
05/30/14,http://twitter.com/prime_oncology/status/472512865770147840,prime_oncology,"James Armitage now leading the Oncology Guru hematology quiz in CLL at the #primeonc symposium at #ASCO14
http://t.co/T2gXinzUK0 #lymsm",8.647796,http://twitter.com/prIME_Oncology/status/472512865770147840,http://twitter.com/prime_oncology
05/31/14,http://twitter.com/mtmdphd/status/472733510289997824,mtmdphd,#ASCO14 - Abrams - @theNCI MATCH Eligibility - solid tumors or lymphoma. #lymsm http://t.co/GmIPYSfjNR,10.790713,http://twitter.com/mtmdphd/status/472733510289997824,http://twitter.com/mtmdphd
05/31/14,http://twitter.com/ncimedia/status/472739152963076097,ncimedia,RT @mtmdphd: #ASCO14 - Abrams - @theNCI MATCH Eligibility - solid tumors or lymphoma. #lymsm http://t.co/GmIPYSfjNR,6.7986674,http://twitter.com/NCIMedia/status/472739152963076097,http://twitter.com/ncimedia
05/31/14,http://twitter.com/bmtjolene/status/472766215056662528,bmtjolene,"$TGTX's ublituximab (TG-1101): good monotherapy ORR in CLL/MZL, low(ish) IRR; need more pts to compare to Gazyva &amp; other Txs #ASCO14 #lymsm",8.042047,http://twitter.com/BMTJolene/status/472766215056662528,http://twitter.com/bmtjolene
05/31/14,http://twitter.com/bmtedny/status/472784246029828096,bmtedny,"RT @BMTJolene: $TGTX's ublituximab (TG-1101): good monotherapy ORR in CLL/MZL, low(ish) IRR; need more pts to compare to Gazyva &amp; other Txs…",6.361091,http://twitter.com/BMTEdny/status/472784246029828096,http://twitter.com/bmtedny
05/31/14,http://twitter.com/drmarkham/status/472787275944710144,drmarkham,"#lymsm MT @NEJM: RESONATE: Ibrutinib improves PFS, overall survival, and RR, in prev treated CLL. #ASCO14 http://t.co/Opb5EWtbzR",11.276168,http://twitter.com/DrMarkham/status/472787275944710144,http://twitter.com/drmarkham
05/31/14,http://twitter.com/carmenbphillips/status/472787415816347648,carmenbphillips,"RT @DrMarkham: #lymsm MT @NEJM: RESONATE: Ibrutinib improves PFS, overall survival, and RR, in prev treated CLL. #ASCO14 http://t.co/Opb5EW…",6.8631554,http://twitter.com/CarmenBPhillips/status/472787415816347648,http://twitter.com/carmenbphillips
05/31/14,http://twitter.com/kingsteub/status/472789484149678080,kingsteub,"RT @prIME_Oncology: James Armitage now leading the Oncology Guru hematology quiz in CLL at the #primeonc symposium at #ASCO14
http://t.co/T…",6.9276,http://twitter.com/Kingsteub/status/472789484149678080,http://twitter.com/kingsteub
05/31/14,http://twitter.com/hcaoncnursenav/status/472794069622861824,hcaoncnursenav,"RT @DrMarkham: #lymsm MT @NEJM: RESONATE: Ibrutinib improves PFS, overall survival, and RR, in prev treated CLL. #ASCO14 http://t.co/Opb5EW…",6.8631554,http://twitter.com/HCAOncNurseNav/status/472794069622861824,http://twitter.com/hcaoncnursenav
05/31/14,http://twitter.com/prime_oncology/status/472799995058724864,prime_oncology,"Tonight at 7 at the Hyatt Chicago: a symposium on CLL and NHL at #ASCO14
http://t.co/qr5EsWnVHT http://t.co/JhVS45LnAl #lymsm #primeonc",7.373386,http://twitter.com/prIME_Oncology/status/472799995058724864,http://twitter.com/prime_oncology
05/31/14,http://twitter.com/maurerstats/status/472818355217657856,maurerstats,Rt @lymphomahub @StefanoLuminari: #ASCO14 dr.Levy conclusions on romulus trial  @lymphomahub http://t.co/VlOgeMOuqz #lymsm,8.087997,http://twitter.com/MaurerStats/status/472818355217657856,http://twitter.com/maurerstats
05/31/14,http://twitter.com/maurerstats/status/472823573644853248,maurerstats,MT @Lymphoma_Doc @GregNowakowski RCHOP + lenalidomide shows GCB=non-GCB DLBCL outcomes. Len+chemo trials planned at MDACC. #ASCO14 #lymsm,6.4698997,http://twitter.com/MaurerStats/status/472823573644853248,http://twitter.com/maurerstats
05/31/14,http://twitter.com/bmtjolene/status/472843086909829120,bmtjolene,"@BMTEdny Also lots of ADC talks in Sunday Lymphoma session @#ASCO14; go bioconjugation! ($SGEN, $IMGN) #lymsm",6.9642572,http://twitter.com/BMTJolene/status/472843086909829120,http://twitter.com/bmtjolene
06/01/14,http://twitter.com/prime_oncology/status/472899017849180160,prime_oncology,Key Takeways from tonight's symposium on #CLL &amp; #NHL presented by John Gribben at #ASCO14 #lymsm #prIMEonc http://t.co/A9vDCpwVUS,6.9488053,http://twitter.com/prIME_Oncology/status/472899017849180160,http://twitter.com/prime_oncology
06/01/14,http://twitter.com/prime_oncology/status/472904802750713856,prime_oncology,prIME points from tonight's symposium on #CLL &amp; #NHL presented by Richard Furman at #ASCO14 #lymsm #prIMEonc http://t.co/GJbjPFqnoU,8.19912,http://twitter.com/prIME_Oncology/status/472904802750713856,http://twitter.com/prime_oncology
06/01/14,http://twitter.com/thedura01/status/472905768413302784,thedura01,RT @prIME_Oncology: prIME points from tonight's symposium on #CLL &amp; #NHL presented by Richard Furman at #ASCO14 #lymsm #prIMEonc http://t.c…,6.7566495,http://twitter.com/TheDura01/status/472905768413302784,http://twitter.com/thedura01
06/01/14,http://twitter.com/prime_oncology/status/472911174636675072,prime_oncology,James Armitage's conclusions from his presentation on #NHL at #ASCO14 #lymsm #prIMEonc http://t.co/QPjGFflYnX,8.89335,http://twitter.com/prIME_Oncology/status/472911174636675072,http://twitter.com/prime_oncology
06/01/14,http://twitter.com/ci4cc/status/472914278899400705,ci4cc,RT @prIME_Oncology: prIME points from tonight's symposium on #CLL &amp; #NHL presented by Richard Furman at #ASCO14 #lymsm #prIMEonc http://t.c…,6.7566495,http://twitter.com/CI4CC/status/472914278899400705,http://twitter.com/ci4cc
06/01/14,http://twitter.com/ci4cc/status/472914478103687168,ci4cc,RT @prIME_Oncology: James Armitage's conclusions from his presentation on #NHL at #ASCO14 #lymsm #prIMEonc http://t.co/QPjGFflYnX,7.0567803,http://twitter.com/CI4CC/status/472914478103687168,http://twitter.com/ci4cc
06/01/14,http://twitter.com/prime_oncology/status/472915383130005504,prime_oncology,Brad Kahl wraps up excellent symposium. prIME points from his presentation on #NHL at #ASCO14 #lymsm #prIMEonc http://t.co/KiuJxxW9SP,7.2788925,http://twitter.com/prIME_Oncology/status/472915383130005504,http://twitter.com/prime_oncology
